Home Blog Page 53

Flying the flag

Make It Happen!’s opening session heard from representatives of three service user-driven organisations

Sophie Strachan‘I’m a recovering addict,’ Sophie Strachan of Positively UK told delegates at Make It Happen!’s opening session. ‘I’ve chosen complete abstinence. I’m also HIV-positive and have been living with HIV for 11 years.’

Positively UK had been an established charity since 1987, she told the conference, after being set up in someone’s living room. ‘We go to clinics and prisons and we’re all living with HIV – it’s the therapeutic value of one person helping another. We’d love to go into more prisons but we don’t receive any funding for that.’

Her organisation also had a mentoring programme, she told delegates – recruiting and training people to Open College Network accreditation level – as well as a pregnancy project, a youth project and a forthcoming a children and family project. ‘It’s that single intervention of alleviating isolation, because so many people with HIV live in isolation.’

Issues for HIV positive drug users included co-infection of hepatitis C and drug-resistant TB as well as denial of problematic drug use and their HIV diagnosis, she said. ‘I have a big group of friends and some of them don’t want to get tested, but there are so many positives – excuse the pun – about knowing your status. Knowledge is power – you get to look after your health and reduce onward infection.’

Anyone living with HIV knew the impact that the associated stigma could have, she told the conference. ‘At one point it was thought that having access to treatment would help to reduce that, but that hasn’t happened. People aren’t informed, and we can play a key role in that – I’m one face of thousands of people living with HIV.’

Peer support was vital, she stressed. ‘When I got my diagnosis I was in prison, and it was another positive person who sowed the seed of hope. We know that peer support works.’

Positively UK was also involved in lobbying, advocating, capacity building and human rights awareness, she said, producing a report called HIV behind bars that looked in depth at human rights abuses in UK prisons, including gender-based violence.

‘I’ve turned my HIV into a gift,’ she said. ‘I felt so powerless when I was given the diagnosis – I was raging – but I’ve turned that around. No one should have to deal with a diagnosis alone. And they don’t.’ 


Danny McCubbinDanny McCubbin of the San Patrignano UK Association described how the Italian  long-term residential rehab facility had helped more than 25,000 people since it was founded in 1978, with a 72 per cent success rate and 1,300 people currently on the programme.

‘It’s similar to a kibbutz,’ he said of the Rimini-based community. ‘Everyone gets involved in the cooking and farming and helping out.’ San Patrignano had quickly begun selling its own produce and was now firmly established as a social enterprise, he explained, marketing a range of products including furniture, glassware, ceramics and cheese. The facility received no government funding but raised millions of euros a year through sales and charitable donations. ‘When I first visited I expected it to be very hippy-herbal, but nothing prepared me for the enormity of it,’ he said.

‘There’s no one story when it comes to addiction – everyone has their own story,’ he stated. ‘At San Patrignano young people are given the context to confront why they took drugs in the first place, and after that they can start to rebuild their lives.’

The whole process took three to four years, he said, with the first the most intense. ‘It’s very, very hard work and there are a lot of rules. The first year is incredibly strict, but when people come to the community they learn to respect each other.’

The UK association helped people to go to San Patrignano and offered opportunities to those who had been through the community, he said, and its aim was now to make links with like-minded organisations. ‘It’s very challenging for young people in this country to have a voice in terms of what they want for their recovery. What I love about the community is that it’s based on the individual. It offers a chance for young people to develop lasting skills and build pride in their achievements. It’s one of the most successful drug rehabilitation projects in the world, and I think that governments should really be taking notice.’


David LawsonDavid Lawson of DISC’s peer-led recovery community, BRIC (Building Recovery in Communities), then told the conference what had led him to user involvement. ‘My childhood was quite happy – I enjoyed school and sports and I went on to be a sea cadet. I wanted to join the marines. So how did I go from that to living in the back of a shed in Grimsby?’

He’d been in and out of prison since 1986, he said, and as his drug use grew so did the length of the sentences. ‘I knew that I was going to die. All my relationships had been ruined, and I felt safe in prison.’ After he was released, however, he made the decision to engage with treatment services.

‘Accepting help was my first step on the road to recovery. Recovery is everywhere, all around us. We might not see it but it continues to grow, and everybody’s journey is different. I reduced in the community – with the right support it is possible to detox in the community. I’m also a member of NA and I used to go around saying that was the only way to do it, but it has to be about choice. It’s horses for courses – that’s the only way – and as I’ve healed my family have needed time to heal as well. I’ve become more responsible and started to build up relationships with them.’

Part of how that had happened had been through user involvement, he stressed. ‘It’s all about relationships for me. For many years I distanced myself – through guilt and shame – and it was difficult for me to have relationships. All of that’s changed now, through recovery. It’s also about looking after myself, because I’ve damaged my body. But I want to live.

‘The last thing I wanted to do was work in services, believe me,’ he told delegates. ‘It can be challenging, we can be adult babies – we want what we want and we want it now – but I get so much from working with people. You’re all flying the flag for recovery, and showing that recovery is possible. We made this happen.’

www.positivelyuk.org

www.sanpatrignano.org

The state we’re in

Paul AndersPaul Anders shares some key findings from, and the thinking behind, the Recovery Partnership’s State of the sector 2013 report. 

Drug treatment in the UK is regarded as world class – effective, evidence-based and supported by a wealth of data, with figures from the National Drug Treatment Monitoring System (NDTMS) showing how far the sector has come.

However, it’s now acknowledged that treatment itself is only one of the things that contribute to a successful outcome. Making a long-term trans­formation relies on a range of factors – referred to as recovery capital – that can be boiled down to straight­forward ideas like improved health, a job, somewhere to live and friends. Building these resources is an important part of starting to make a change, and often an essential part of sustaining it.

The advantages to building recovery capital are clear but the environment is, if not hostile, then certainly challenging. The treatment sector is in a state of flux and the external environment is also changing, with jobs and homes hard to come by and public services undergoing significant changes.

The Recovery Partnership was keen to learn more about how the sector is adapting to the changing environment, and how it is managing to provide the type of support needed to build lasting recovery. While NDTMS and the other hard data the sector collects tell an important story, to learn more about non-treatment related activity and the reality at a local level, talking to services and the people who work in them was crucial.

The State of the sector 2013 research (see news story, page 4) aimed to do this by a number of means – an online survey, telephone interviews with chief executives and local managers and four regional ‘Building Recovery in Communities’ summits last autumn in which more than 200 people participated. The survey itself was completed by around 170 services, while around a dozen interviews were conducted, primarily with services in local authority areas where there was an especially low or especially high public health allocation.

Given the breadth of what the Recovery Partnership wanted to learn about, it’s hardly surprising that the findings are best described as mixed. Some key points include:

 • There is no evidence so far of systemic disinvestment. Roughly twice as many services reported a decrease compared to those reporting an increase, but the average increase was larger than the average decrease. This may be evidence of a trend towards larger contracts and fewer providers in a given area and this is consistent with in-year figures from the Department for Communities and Local Government, which suggest that, broadly speaking, funding has been maintained in 2013-14.

• There is some engagement with health and wellbeing boards and police and crime commissioners, but variable levels of awareness of the contents of joint strategic needs assessments (JSNAs) and police and crime plans – particularly the latter. Where people were aware of the contents of local plans and assessments, several expressed concern that the focus was more on crime and anti-social behaviour than treatment. In the case of JSNAs, there were concerns that drugs and alcohol were insufficiently reflected, which may not be problematic if the boards are working on the principle that if it’s not broken, don’t fix it, but it’s something to watch out for.

Generally, services appear to be facing challenges around supporting people to accumulate recovery capital, with housing, jobs and support for complex or multiple needs all highlighted as areas of concern:

• Housing was the most commonly encountered support need after support to overcome dependency – unsurprising, as NDTMS data indicates many people accessing treatment have some sort of housing problem. However, housing and housing support was the most commonly identified local gap, including the ability to access particular types of accommodation, such as drug and/or alcohol-free supported housing.

• Management of overall health was the second most encountered support need. While availability of physical or general health services does not seem problematic, more respondents felt that access to mental health services had worsened than improved over the last 12 months. Several expressed concern about the threshold for mental health support and that raising it meant that many people were going without. The problem of support for people with complex needs or dual diagnosis remains unresolved.

• Employment, training and education (ETE) came fourth on the list of support needs and was the third most mentioned local gap. What’s interesting is that, in response to another question, very few respondents said ETE support wasn’t available locally, and many services reported a partnership with Jobcentre Plus and/or Work Programme providers. It may be that while the support is available, it isn’t achieving the sort of results services would like to see and be part of.

In short, while the findings aren’t calamitous – and in some respects are pretty positive – there are some areas of work that look as though they’re struggling, and many of the areas where services and partnerships appear to be facing difficulty are related directly to recovery capital.

Later this year, we’ll be repeating the exercise to see how the sector is faring now that the new commissioners and funders are bedded in, and we’ll be looking in more detail at the findings from 2013. As State of the sector 2013 focused primarily on community and residential drug and alcohol treatment, we’re also aiming to do some work looking at prison treatment and young people’s services. Please keep your eyes open for them – the more people who take part, the more reliable the findings will be.

 

Full report at www.drugscope.org.uk

Paul Anders is senior policy officer at DrugScope

Scottish alcohol-related deaths fall nearly 40 per cent in a decade

Alcohol-related death rates in Scotland fell by 37 per cent – from 39.5 to 24.8 per 100,000 population – in the ten years to 2012, according to figures from the Office for National Statistics (ONS). Death rates in England rose by 2 per cent over the same period, although at 14.7 per 100,000 population in 2012 they remain much lower than Scotland’s.

There were 8,367 alcohol-related deaths in the UK overall in 2012, 381 fewer than the previous year, with males accounting for 65 per cent of the deaths. Death rates were highest among men aged 60-64.

Meanwhile, a new modelling study from the Sheffield Alcohol Research Group has concluded that minimum pricing is an effective way to target high-risk drinkers, with ‘negligible’ effects on low-income, moderate drinkers. ‘Because harmful drinkers on low incomes purchase more alcohol at less than the minimum unit price threshold compared with other groups, they would be affected most’ by a policy of a minimum price of 45p per unit, says Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study. Much of the opposition to minimum pricing has been based on the impact it could have on moderate drinkers.

A 45p minimum price would mean an estimated 860 fewer alcohol-related deaths per year, says the study, and nearly 30,000 fewer hospital admissions. The research provided ‘further evidence’ of the effectiveness of the policy, said director of the Centre for Public Health Excellence at NICE, Professor Mike Kelly.

The Home Office has also announced 20 new ‘local alcohol action areas’ across England and Wales, with licensing authorities, health bodies and the police working together to address drink-related crime and ill health. The areas had ‘the potential to build strong evidence of what works to tackle alcohol harms in the community’, said director of health and wellbeing at Public Health England, Professor Kevin Fenton.

Alcohol-related deaths in the United Kingdom, registered in 2012 at www.ons.gov.uk

Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study at www.thelancet.com

 

Government accepts ACMD’s ketamine recommendation

Ketamine is to be upgraded to a class B drug, crime prevention minister Norman Baker has confirmed. Baker has written to Advisory Council on the Misuse of Drugs (ACMD) chair Sir Les Iversen to say that he accepts the council’s recommendation that the drug be reclassified in the light of health concerns and the numbers of people seeking treatment (DDN, January, page 5).

The government will now consult to assess the impact of reclassifying on the medical and health sectors, said Baker, with the parliamentary process to reclassify to begin ‘shortly’. Excessive ketamine use has been associated with a range of health harms including chronic bladder and other urinary tract damage. However, Baker acknowledges in the letter that ‘ketamine use in adults in the UK has gone down in the past two years, although it is too early to establish whether this downward trend will continue’.

Meanwhile, the latest figures from the National Programme on Substance Abuse Deaths (NPSAD) at St George’s, University of London, show a 600 per cent increase in the number of deaths caused by new psychoactive substances between 2009 and 2012 – from 10 to 68. The prevalence of the new drugs in post-mortem toxicology reports also increased from 12 cases to 97 over the same period.

The total number of drug-related deaths reported to NPSAD during 2012 was 1,613. Opiates – alone or in combination with other drugs – accounted for 36 per cent, up 4 per cent on 2011 and reversing the declining trend of recent years (DDN, March 2013, page 5). There was also an increase in the proportion of deaths involving stimulants including cocaine, following a decline in 2009 and stabilisation in 2010.

London had the highest proportion of cocaine-related deaths at 15.2 per cent, while Liverpool recorded more drug-related deaths than Manchester for the first time since 2006.  The highest rates of drug-related deaths per 100,000 adult population were in the DAAT areas of Liverpool (12.57 per cent), Blackburn with Darwen (11.45 per cent) and the London Borough of Hammersmith and Fulham (11.34 per cent). More than 72 per cent of deaths were in males, and more than 67 per cent in under-45s. 

‘We have observed an increase in the number and range of [novel psychoactive substances] in the post mortem toxicology results and in the cause of death of cases notified to us,’ said NPSAD spokesperson Professor Fabrizio Schifano.  Clearly this is a major public health concern and we must continue to monitor this worrying development. Those experimenting with such substances are effectively dancing in a minefield.’

A third of services report funding decrease

More than a third (35 per cent) of drug and alcohol services reported a decrease in funding last year, according to a report from DrugScope, compared to just a fifth that reported an increase. More than half also reported large increases in caseloads.

The funding picture is ‘mixed and complex’, says State of the sector 2013 – which is published on behalf of the Recovery Partnership – although there are so far ‘no clear signs’ of widespread disinvestment. The potential effect of frequent recommissioning and retendering was also a concern, however, in terms of staff morale and disruption to service provision, while public health restructuring and changes to criminal justice commissioning have also had a ‘significant impact’. Some services reported a lack of engagement with police and crime commissioners and health and wellbeing boards, although others said relationships had now been established.

Almost 170 services from across the country were surveyed for the report, with many respondents highlighting ‘significant’ problems in offering support around housing, employment and mental and physical wellbeing. Almost half, meanwhile, said they were employing fewer frontline staff and six out of ten reported an increase in the use of volunteers.

‘Public service delivery of all kinds has undergone a period of significant transformation in recent years,’ said DrugScope chief executive Marcus Roberts. ‘It’s clear that organisations delivering drug and alcohol treatment are facing challenges, not only related to funding, but also to engagement with the new structures shaping service delivery on the ground. There is a concern about securing access to some of the vital resources that support recovery, including housing and employment.

‘However, responding to the challenges, it is heartening to hear that the agencies which took part in the research are adapting and innovating in the new environment,’ he continued. ‘The priority is to keep providing support to those who need it – and many agencies are developing new partnerships with and beyond the sector to ensure they support the ambitions and aims of people in recovery.’

Report at www.drugscope.org.uk

See March’s news focus 

Improved support needed for older people

Improved support is needed for older people with drug and alcohol issues, says a new report from DrugScope. While the focus of policy and media attention remains young people, there is a significant and growing problem with older people’s use of substances, says the charity.

Alcohol-related hospital admissions for men and women over 65 rose by 136 and 132 per cent respectively in the eight years to 2010, says It’s about time: tackling substance misuse in older people, while alcohol-related death rates among over-75s are now at their highest recorded level.

While the aging population being treated for heroin problems has become, according to Public Health England (PHE), one of the ‘key features of drug treatment in England’, and many of the trends highlighted in the report ‘partly reflect the health consequences of long-term drug or alcohol use’, there are also a significant number of ‘late starters’ using substances to self-medicate the physical and mental issues associated with growing old, it stresses. The physiological changes associated with getting older also mean that this population group can be at increased risk of adverse effects from substance misuse, ‘even at relatively modest levels’.

While there is some effective service provision for older people, more awareness is needed as a first step to providing age-appropriate specialist services as well as better support in primary and social care settings, says the report. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) estimates that the number of older people needing treatment for substance misuse will have more than doubled from 2001’s figure by 2020.

Among the report’s recommendations are ‘age-appropriate, non-time-limited treatment’ for people who are drug or alcohol-dependent, as well as brief interventions for people drinking at risk and support for problems with prescription or over-the-counter medications. Commissioners also need to recognise the importance of services for older people and ensure continued funding, while services themselves should make sure their services are accessible and relevant to this client group.

‘Drugs and alcohol issues may affect older people differently, but that does not make them less real or important,’ said DrugScope chief executive Marcus Roberts. ‘They may be a symptom of other problems, such as loneliness and isolation, caring for a partner, bereavement or the struggle to make ends meet. The facts and figures in the report speak for themselves and with the numbers of older people as a percentage of the population continuing to rise, this is not an issue that we can ignore.’

Barriers to accessing support need to be addressed, he urged, ranging from embarrassment at having to ask for help to a belief among professionals that ‘older people can’t change’. ‘It’s time to bring this largely “invisible” issue into the light and to improve the support for older people with drug and alcohol issues.’

Report at www.drugscope.org.uk

News in brief

Voicing concerns

Public Health England (PHE) has not yet ‘found its voice’, developed a clear set of priorities or demonstrated that it is sufficiently independent of the Department of Health, according to a report from the Health Committee. There was now an ‘urgent need’ for PHE to show it could ‘speak truth unto power’, said committee chair Stephen Dorrell MP. ‘PHE should not look to the Department [of Health] or other parts of government to prompt its research or, still less, to authorise its findings,’ he stated. ‘PHE can only succeed if it is clear beyond doubt that its public statements and policy positions are not influenced by government policy or political considerations.’

Public Health England at www.parliament.uk

Council call

The Local Government Association (LGA) has called on social media companies to introduce health warnings about internet drinking game NekNomination. ‘This is an utterly reckless and totally irresponsible craze which has tragically claimed lives,’ said chair of the organisation’s wellbeing board, Katie Hall. ‘The LGA is looking for these corporations to show leadership and not ignore what is happening on their sites. We are urging Facebook and Twitter executives to sit down with us and discuss a way forward which tackles this issue head on.’

Mmm… DANOS

The revised National Occupational Standards (NOS) for drug and alcohol workers have now been launched by Skills for Health. ‘The continued development of competent practitioners, volunteers, managers and commissioners in the substance use sector is crucial for the delivery of high quality effective services which meet the needs of the individuals and communities we serve,’ said FDAP chief executive Carole Sharma.

Revised DANOS at tools.skillsforhealth.org.uk/competence_search/

Stopping stereotypes

A youth alcohol summit organised by Alcohol Concern saw young people call on policy-makers to see them as ‘part of the solution to the alcohol problems the country is facing, not part of the problem’ and attempt to challenge stereotypical views of the young as binge drinkers. ‘Young people are often spoken about in alcohol policy discussions but rarely asked for their views,’ said Alcohol Concern policy programme manager, Tom Smith. ‘It’s time for this to change.’ 

In denial

The International Narcotics Control Board (INCB) has expressed ‘concern’ at US initiatives to legalise the ‘non-medical and non-scientific’ use of cannabis. Launching its annual report, INCB president Raymond Yans said the organisation ‘deeply regretted’ developments in Colorado and Washington, which ‘contravene the provisions of the drug control conventions’. INCB was ‘in denial’ of calls for a meaningful debate on global drug policy, however, said International Drug Policy Consortium (IDPC) executive director Ann Fordham. ‘The board is apparently oblivious to the growing number of member states questioning the status quo and exploring alternative policies.’

INCB annual report 2013 at www.incb.org

Poor provision

Homelessness services are still failing to support women effectively, says the final report of the St Mungo’s Rebuilding shattered lives project, as they are predominantly designed by, and for, men. More than 10,000 women accessed UK homelessness services last year, says the document, with many more ‘hidden’ homeless. ‘This report evidences a sad chronicle of missed opportunities where women fail to get the help they need,’ said St Mungo’s chief executive Charles Fraser. ‘National leadership is key.’

Report at www.mungos.org

Winging it

Prison drug recovery wings (DRWs) need to be segregated from the wider establishment, with clear referral pathways and strong support from senior management, says a new report from the National Offender Management Service (NOMS). Commissioners should also consider delivering ‘a range of recovery-focused interventions including accredited drug treatment programmes’ as part of their DRW regimes says the document, which studies the five DRWs launched in 2011.

Drug recovery wings set up, delivery and lessons learned: process study of first tranche DRW pilot sites at www.gov.uk

Vital signs

The London Drug and Alcohol Policy Forum (LDAPF) has launched a new version of its Vital info guide to drugs and their associated risks. Available free in leaflet form from ldapf@cityoflondon.gov.uk or to download at www.cityoflondon.gov.uk/ldapf, with an optimised web version coming soon.

March 2014

March DDN 2014In this month’s issue of DDN… 

‘There’s no one story when it comes to addiction – everyone has their own…’

March’s DDN  is the Make It Happen! conference special issue, featuring vibrant pictures from the day, quotes from delegates and inspiring coverage of all the speakers.

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page.

Read the PDF Version

Be part of the DDN Conference 2026 on 9 July Birmingham. Find out more

More support needed for older people with drug and alcohol problems

Improved support is needed for older people with drug and alcohol issues, says a new report from DrugScope. While the focus of policy and media attention remains young people, there is a significant and growing problem with older people’s use of substances, says the charity.

Alcohol-related hospital admissions for men and women over 65 rose by 136 and 132 per cent respectively in the eight years to 2010, says It’s about time: tackling substance misuse in older people, while alcohol-related death rates among over-75s are now at their highest recorded level.

While the ageing population being treated for heroin problems has become, according to Public Health England (PHE), one of the ‘key features of drug treatment in England’, and many of the trends highlighted in the report ‘partly reflect the health consequences of long-term drug or alcohol use’, there are also a significant number of ‘late starters’ using substances to self-medicate the physical and mental issues associated with growing old, it stresses.
The physiological changes associated with getting older also mean that this population group can be at increased risk of adverse effects from substance misuse, ‘even at relatively modest levels’.

While there is some effective service provision for older people, more awareness is needed, says the report, as a first step to providing age-appropriate specialist services as well as better support in primary and social care settings. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) estimates that the number of older people needing treatment for substance misuse will have more than doubled from 2001’s figure by 2020.

Among the report’s recommendations are ‘age-appropriate, non-time-limited treatment’ for people who are drug or alcohol-dependent, as well as brief interventions for people drinking at risk and support for problems with prescription or over-the-counter medications. Commissioners also need to recognise the importance of services for older people and ensure continued funding, while services themselves should make sure their services are accessible and relevant to this client group.

‘Drugs and alcohol issues may affect older people differently, but that does not make them less real or important,’ says DrugScope chief executive Marcus Roberts. ‘They may be a symptom of other problems, such as loneliness and isolation, caring for a partner, bereavement or the struggle to make ends meet. The facts and figures in the report speak for themselves and with the numbers of older people as a percentage of the population continuing to rise, this is not an issue that we can ignore.’
Barriers to older people accessing help and support need to be addressed, he urged, ranging from embarrassment at having to ask for help to a belief among professionals that ‘older people can’t change’. ‘It’s time to bring this largely “invisible” issue into the light and to improve the support for older people with drug and alcohol issues.’

Report at www.drugscope.org.uk

Make It Happen! feedback form

[contact-form-7 id=”7893″ title=”Make It Happen feedback form”]

A third of services report funding decrease

More than a third (35 per cent) of drug and alcohol services reported a decrease in funding last year, according to a new report from DrugScope, compared to just a fifth that reported an increase. More than half also reported large increases in caseloads.

The funding picture is ‘mixed and complex’, says State of the sector 2013 – which is published on behalf of the Recovery Partnership – although there are so far ‘no clear signs’ of widespread disinvestment. The potential impact of frequent recommissioning and retendering was also a concern, however, in terms of staff morale and disruption to service provision, while public health restructuring and changes to criminal justice commissioning have also had a ‘significant impact’. Some services reported a lack of engagement with police and crime commissioners and health and wellbeing boards, although others said relationships had now been established.

Almost 170 services from across the country were surveyed for the report, with many respondents highlighting ‘significant’ problems in offering support around housing, employment and mental and physical wellbeing. Almost half, meanwhile, said they were employing fewer frontline staff and six out of ten reported an increase in the use of volunteers.

‘Public service delivery of all kinds has undergone a period of significant transformation in recent years,’ said DrugScope chief executive Marcus Roberts. ‘It’s clear that organisations delivering drug and alcohol treatment are facing challenges, not only related to funding, but also to engagement with the new structures shaping service delivery on the ground. There is a concern about securing access to some of the vital resources that support recovery, including housing and employment.

‘However, responding to the challenges, it is heartening to hear that the agencies which took part in the research are adapting and innovating in the new environment,’ he continued. ‘The priority is to keep providing support to those who need it – and many agencies are developing new partnerships with and beyond the sector to ensure they support the ambitions and aims of people in recovery.’

Report at www.drugscope.org.uk

Government accepts ACMD’s ketamine recommendation

Ketamine is to be upgraded to a class B drug, crime prevention minister Norman Baker has confirmed. Baker has written to Advisory Council on the Misuse of Drugs (ACMD) chair Sir Les Iversen to say that he accepts the council’s recommendation that the drug be reclassified in the light of the health concerns associated with it and the numbers of people seeking treatment (DDN, January, page 5). 

The government will now consult to assess the impact of reclassifying on the medical and health sectors, said Baker, with the parliamentary process to reclassify to begin ‘shortly’. Excessive ketamine use has been associated with a range of health harms including chronic bladder and other urinary tract damage. However, Baker acknowledges in the letter that ‘ketamine use in adults in the UK has gone down in the past two years, although it is too early to establish whether this downward trend will continue’. 

Meanwhile, the latest figures from the National Programme on Substance Abuse Deaths (NPSAD) at St George’s, University of London, show a 600 per cent increase in the number of deaths caused by new psychoactive substances between 2009 and 2012 – from 10 to 68. The prevalence of the new drugs in post-mortem toxicology reports also increased from 12 cases to 97 over the same period. 

The total number of drug-related deaths reported to NPSAD during 2012 was 1,613. Opiates – alone or in combination with other drugs – accounted for 36 per cent, up 4 per cent on 2011 and reversing the declining trend of recent years (DDN, March 2013, page 5). There was also an increase in the proportion of deaths involving stimulants including cocaine, following a decline in 2009 and stabilisation in 2010. 

London had the highest proportion of cocaine-related deaths at 15.2 per cent, while Liverpool recorded more drug-related deaths than Manchester for the first time since 2006. Deaths in Northern Ireland, however, showed ‘a marked difference from the rest of the UK’, with most linked to prescription drugs like tramadol, benzodiazepines and anti-depressants. The highest rates of drug-related deaths per 100,000 adult population were in the DAAT areas of Liverpool (12.57 per cent), Blackburn with Darwen (11.45 per cent) and the London Borough of Hammersmith and Fulham (11.34 per cent). More than 72 per cent of deaths were in males, and more than 67 per cent in under-45s. Accidental poisoning accounted for 68 per cent of the deaths. 

‘We have observed an increase in the number and range of [novel psychoactive substances] in the post mortem toxicology results and in the cause of death of cases notified to us,’ said NPSAD spokesperson Professor Fabrizio Schifano. ‘These include amphetamine-type substances, dietary supplements, ketamine derivatives, among a host of others. The worrying trend is that these type of drugs are showing up more than ever before. Clearly this is a major public health concern and we must continue to monitor this worrying development. Those experimenting with such substances are effectively dancing in a minefield.’

Government to opt out of EU directive on new drugs

The UK government will opt out of the European Commission’s proposals for a directive and other regulation on new psychoactive substances, it has announced.

The government ‘strongly disputes’ the conclusion of an EU Commission impact assessment that around 20 per cent of new psychoactive substances have a legitimate use, said crime prevention minister Norman Baker in a written statement. The EU’s proposals would also ‘fetter the UK’s discretion to control different new psychoactive substances, binding the UK to an EU system which would take insufficient account of our national circumstances’, he stated. The government is currently conducting its own wide-ranging review into the laws relating to new drugs (DDN, January, page 4), with the conclusions to be announced in the spring.

‘New psychoactive substances pose a significant global challenge and the decision to opt out should not in any way be considered to diminish our commitment to tackle this issue,’ said Baker. ‘We are looking at a range of options including legislative ones to enable us to deal with the dangers many of these substances present even more speedily and effectively.’

Meanwhile, police in Scotland have issued a warning about a batch of tablets in circulation containing para-Methoxyamphetamine (PMA). The tablets, which are being sold as ecstasy, are pink with a ‘Superman’ logo on one side and ® logo on the other.

As PMA can take longer to have an effect than MDMA, the risk is that people take repeat doses in the belief that the drugs aren’t working. The substance was linked to deaths and hospitalisations last summer (DDN, August 2013, page 5), prompting the Department of Health to issue a health alert. Scottish police and health services have also issued warnings about red ‘mortal kombat’ tablets featuring an image of a dragon, following the recent death of a woman in Glasgow and four other people being hospitalised.

Government bans below-cost alcohol sales

Legislation banning the sale of below-cost alcohol is to come into force in April, subject to Parliamentary approval, the government has announced.

The Home Office has issued guidance on the ban, which was first announced last summer following a consultation on the government’s alcohol strategy (DDN, August 2013, page 4). The announcement angered many health campaigners who had instead wanted to see a minimum price per unit of alcohol.

Below-cost sales bans are seen as an unsatisfactory compromise by organisations calling for a minimum unit price, as well as unnecessarily difficult to calculate. ‘Cost’ is defined as ‘the level of alcohol duty for a product plus value added tax payable on the duty element of the product price’, says the guidance. According to the document, a 440ml can of 4 per cent lager could not be sold for less than 41p, or a 9 per cent can for less than £1.16. A 70cl bottle of 37.5 per cent vodka, meanwhile, would cost at least £8.89 and a 750ml bottle of 12.5 per cent wine £2.41.

The government’s response to its alcohol strategy consultation also dropped plans to ban multi-buy promotions, and businesses will still be able to offer ‘buy one get one free’ deals as long as the total purchase price ‘is not below the aggregate of the duty plus VAT permitted price for each product comprised in the package’. The ban will be enforced by local authorities, trading standards officers and the police, although the guidance recommends that ‘enforcement officers only check the prices of heavily discounted alcohol products’ rather than all alcohol on sale at the premises.

‘The idea that banning below-cost sales will help tackle our problem with alcohol is laughable,’ said Alcohol Concern chief executive Eric Appleby. ‘It’s confusing and close to impossible to implement. On top of this, reports show it would have an impact on just 1 per cent of alcohol products sold in shops and supermarkets, leaving untouched most of those drinks that are so blatantly targeted at young people. The government is wasting time when international evidence shows that minimum unit pricing is what we need to save lives and cut crime.’

Guidance on banning the sale of alcohol below the cost of duty plus VAT: for suppliers of alcohol and enforcement authorities in England and Wales at www.gov.uk

Helping hands

Jenni ParkerJenni Parker tells DDN about the Aurora Project Lambeth, a social enterprise that offers volunteer-led peer mentoring to people in treatment. 

The Aurora Project Lambeth is situated in a quiet office on Stockwell Road in Brixton, south London and was set up three years ago by a group of service users from Lambeth. The project is an independent, not-for-profit social enterprise that is governed by a board made up of service users, local residents and professionals.

The idea behind the project was to offer peer support and mentoring to individuals in treatment for their substance use within the borough, and to promote the belief that those in recovery have much to offer their local communities. It aimed to challenge the stereotype that drug and alcohol users are a burden on society.

The board was successful in securing £110,000 worth of funding from the local primary care trust and the project continues to be funded by the Lambeth local authority. Two years ago I joined the organisation as their only paid member of staff. My challenge? To streamline the project’s operations.

I worked closely with the directors and three service users, who gave their time to the project on a voluntary basis, to recruit volunteers who had been through treatment themselves and were in recovery. We then trained them to be peer mentors and matched them to clients referred to us by the Lambeth Alcohol and Drug Treatment Consortium.

The biggest challenge at this stage was finding volunteers to give their time, but two years on we have a team of 30 trained volunteer peer mentors. One Aurora Project Lambeth volunteer, who joined us six months into his own recovery, said of his experience, ‘My time at Aurora Project Lambeth has been one of the most positive, inspiring and fulfilling times of my life.’

My role involves the ongoing support and management of our volunteer team – ensuring they get a good volunteering experience during their time with the project and ensuring that they provide a great standard of support to others.

Our volunteers offer clients the chance to speak to someone who has ‘been there and done that’. They give practical advice and information on a variety of topics, as well as motivational support and encouragement, whether through attending groups, appointments or meetings. Our volunteers offer clients their time, which is something that they seem to value the most – time to work things out, to talk, to be heard.

‘It’s not clinical,’ said one client of her interaction with an Aurora Project volunteer. ‘I know she understands and she’s been through the same thing.’

In addition to ongoing one-to-one peer mentoring, we also offer clients the chance to come along to our art group, which is facilitated by a trained artist who is in recovery herself. This group allows them to meet and support each other, as well as adding structure to their day-to-day lives. It helps to raise self-esteem – and is also a way of just having fun!

Last year we achieved the approved provider standard, a national quality standard awarded by the Mentoring and Befriending Foundation. This standard was awarded to us because we proved we offer an outstanding experience for our volunteers, supporting them in their roles and in helping them to access further education. It also recognises that our volunteers are trained thoroughly for their role, that the organisation is governed exceptionally well and that we are offering a much needed and effective service for our clients.

There have of course been teething problems along the way. We have learned that although we are an independent organisation, it is vital to have the buy-in and support from the Lambeth Treatment Consortium, ensuring communication channels are always open. We have also learned that offering a high level of support to our volunteers is paramount when asking people in recovery to work directly with clients, many of whom are still living chaotic lifestyles. We do this by offering them clinical supervision, support from staff and ensuring that the volunteers support each other.

The Aurora Project Lambeth continues to grow and has become embedded in the local community.

Jenni Parker is the service delivery manager at Aurora Project Lambeth. www.auroraprojectlambeth.org.uk

A tale of two drinkers

Steve BrinksmanThe challenge of Dry January meant different strokes for different folks, says Dr Steve Brinksman. 

As the role alcohol plays in ill health and social dysfunction is increasingly in the spotlight, the whole SMMGP team decided to support Alcohol Concern by taking part in Dry January. It would be fair to say that it was anticipated that it would be harder some of us (ie me) than some of the others.

I decided that the best approach for me would be to tell as many people as possible that I was taking part, thus feeling compelled to complete it. One of the knock-on effects was that one of my GP partners and his wife decided to join in. I also had several interesting conversations with patients including one with an older lady who said, ‘Oh, I didn’t realise you were an alcoholic and needed to dry out.’ Hopefully she now understands a little more about the concept of dependence.

Frank had an appointment about his high blood pressure. He was taking medication for this and we were discussing adding in another tablet. He is a self-employed plumber and has always admitted to drinking ‘a lot’ at weekends and ‘a few’ during the week. That said, when work was busy he would sometimes go three or even four days without a drink. Now in his mid-40s he had watched his weight go up with his blood pressure, especially after he stopped smoking three years ago. He was surprised when I suggested he consider Dry January, but faced with the prospect of more medication he somewhat begrudgingly agreed it might be worth a go.

Linda, on the other hand, brought up her plan with me to participate in Dry January. She told me a friend at work was intending to sign up to the campaign and she thought she would too. She had a stressful job with a firm of solicitors, had lost her driving licence due to drink-driving 12 months ago and had been seeing the local CBT counselling service for anxiety and depression over the past few months.

This led to a deeper exploration of her drinking habits: she arrived home from work and immediately had a large glass of wine, followed by a couple more during the working week and probably twice this at the weekend.

She had gone a couple of days without a drink earlier in the year when she had flu but said she felt really ill and had been retching and shaky which she blamed on the virus.

An AUDIT (alcohol use disorders identification test) score of 28 supported my view that she probably had a degree of physical dependence, and after some persuasion she agreed to see our alcohol counsellor rather than attempt Dry January. She has done well and over the course of January she has cut back to about half a bottle of wine a day and towards the end of the month has even managed a couple of dry days. She is now focused on getting her licence back and is starting to think that her life might be better without alcohol.

As for Frank he came in looking great, he had lost 4kgs in weight and his blood pressure was back under control. I had thought he might struggle but he told me he had stopped going to the pub and started going for a run: ‘I’d like to do a marathon, Doc. It’s quite addictive this running, you know.’

Steve Brinksman is a GP in Birmingham and clinical lead of SMMGP, www.smmgp.org.uk. He is also the RCGP regional lead in substance misuse for the West Midlands.

Letters

LettersThe DDN letters page, where you can have your say.

To be included in the next issue, please send letters and comments to claire@cjwellings.com.

Committed to naloxone

Regarding Neil Hunt’s opinion piece, ‘A matter of life and death’ (DDN, December 2013, page 18): as the service provider for Peterborough, we are in absolute agreement that naloxone should be available to service users, especially high-risk service users such as those leaving prison and those accessing the needle exchange. We fully appreciate that naloxone is a potentially life saving drug and with minimal training – we provide it to service users and their families on a case-by-case basis.

CRI provide the integrated recovery service in Peterborough, which incorporates prescribing interventions and we have not been aware of any contact made with our service, or with our Peterborough commissioners, in relation to take-home naloxone. Had we been contacted, we would of course have made the drug available. We are keen to make take-home naloxone available to all high-risk drug users in Peterborough and provide training for service users and their families.

Our services in Sefton and East Lancashire are an example of this. Peer mentors, high-risk service users and their families were identified and trained. Naloxone is also made available in the needle exchange, so it is available to people who were not engaged in treatment. Within the first year of the scheme, we had notification from the local ambulance service that the availability of take-home naloxone had saved three people’s lives. We also had several reports from service users, who provided anecdotal evidence that through the use of naloxone, drug-related deaths had been avoided.

We, and commissioners locally, are committed to ensuring that Peterborough has a similar service provision for take-home naloxone and are currently making this available to all high-risk service users across the city.

If the author of the article would like to discuss this further or hear about our success with naloxone in other parts of the country, please do not hesitate to contact us.

Alison Snelling, services manager, CRI Aspire, Peterborough

 

Get certified

Adfam and FDAP have jointly developed a competency-based certification for practitioners supporting families affected by drugs and alcohol. Adfam brings years of experience of working with both families and practitioners to the creation of this unique certification scheme, and FDAP its expertise as the professional body and membership organisation for the substance misuse sector.

Currently FDAP provides certification and accreditation services for drug and alcohol practitioners and counsellors, and accredits university courses which prepare counsellors. We urge those who work with families to consider this process of certification to demonstrate their competence in this area.

The Adfam/FDAP Drug and Alcohol Family Worker Professional Certification provides practitioners with a range of benefits including:

•             A professional competency-based certification mapped to appropriate National Occupational Standards.

•             A role profile and a code of practice to work to.

•             Ongoing support from FDAP/Adfam, including priority invites to events.

This certification is offered at the registration level. Practitioners will, as a minimum, require their employers to attest to their competence in each of the National Occupational Standards outlined in the role profile. They will also be required to develop a portfolio of continued learning to allow them to demonstrate continued professional development in order to re-accredit after three years.

It is in both practitioner and service’s interest to adopt practices which demonstrate a commitment to providing high quality services to the people and communities they serve. Ensuring practitioners remain competent and continue to develop their skills is a major component of quality management.

In this ever more cash-strapped environment with funding being reduced across the board, services are being re-tendered with contracts being awarded to new employers. It is therefore important that practitioners demonstrate the quality of their practice and services demonstrate to commissioners that the systems they utilise provide quality-assured services which effectively respond to the changing needs of the client group. This certification system will support quality management, drive continued professional development for practitioners and assist the commissioning process.

The accreditation costs £75 for three years, and includes a year’s membership of FDAP. For more information please see the FDAP website, www.fdap.org.uk or ring on 0207 234 9798.

Carole Sharma, chief executive, FDAP

 

Perception of doors

CRI’s drug service in Wellington Street, Hastings is, I am sure, a good service but that is not the message sent out by weary signage and a tatty door with peeling paint. Austerity is no excuse. Number ten Downing Street knows how important a symbol a front door can be. It keeps replacement doors. When one door is in need of a refurbishment, a new door replaces the old one immediately. I do not suggest for one moment that CRI can afford to do that, but a lick of paint costs little. When the Hastings service was run by Addaction, when I was in charge of communications – including building signage – the organisation believed that the portal through which frightened and stigmatised clients passed was important. It says you are valued and you are respected. Doors are important.

Rosie Brocklehurst, former director of communications, Addaction, St Leonard’s on Sea, East Sussex

 

Pooling resources

I work for a drugs and alcohol service in Greater Manchester and I’m aware that our team is receiving increasing numbers of referrals for Polish men who speak and read very little English. I’m looking at translating some of our promotional and therapeutic materials (such as drink diaries) into the Polish language. I’d like to hear from other services that may already have undertaken such an exercise – with a view to pooling resources. If you’d like to get in touch please contact me at alan.alker@nhs.net – any attached translated documents would be appreciated.

Alan Alker, team manager/clinical nurse specialist, Pennine Care Trust Drugs and Alcohol Service, Ashton-under-Lyne.

Media savvy

Who’s been saying what..? DDN’s round-up of what’s being said in the national papers

The idea that the existing policy on drugs in this country, and almost everywhere in the world apart from Colorado and Uruguay, is a self-evident failure is not a truth that is self-evident to me. In particular, the ‘war on drugs’, and the notion that it is being ‘lost’, is a cliché that helps to shut down thought rather than encourage it… Legalisers sometimes say that it is jolly confusing that cannabis is illegal in theory but that the police tend to concentrate on more important things in practice. It’s a compromise. It is so sensible that it is the most common legal position all over the world: illegal but not stringently enforced for small amounts. It is intellectually unsatisfactory, but it is winning. The people who want to change it have to make a better case.

John Rentoul, Independent, 7 January

I am worried because I think of legalisation as a symbol. A symbol that the world has become more accepting of living a mediocre life… the more we accept pot and other distractions as perfectly normal, the more we are accepting mediocrity.

Elad Nehorai, Guardian, 7 January

If marijuana is now deemed OK in Colorado – and dispensaries will open soon in Washington as well, the other state that approved legal marijuana at the end of 2012 – what message does that send to Mexico and others fighting the war on drugs largely on America’s behalf?…  As a father I am not thrilled to see marijuana consumption encouraged. What I surely do welcome, however, is the opportunity for the first time to test in practice the argument that legalisation will do more to diminish violence in America’s immediate neighbour and points south than any amount of militarised prohibition.

David Usborne, Independent, 8 January

There’s no one simple and definite solution to substance abuse but the argument for deterrence is not one. If millions want to drink, smoke, snort and swallow then they will, whether it’s expensive or not, whether it’s legal or not. If the government wants them to stop, it needs to give them greater reason to; a reality they don’t want release from. 

Chris Jackson, Independent on Sunday, 26 January 

If the country is supposed to get upset because no gun-toting, drug-peddling gangster is safe on the streets any more then forget it… Gangsters who live by the gun – even those who throw them away when the police close in – should expect to die by the gun. They are vermin whose drug pushing threatens every decent family in the land and if the police happen to take a few out as they clean up the streets then so be it.

Chris Roycroft-Davis, Express, 10 January

[David Cameron] tried to pin the blame for Britain’s drinking culture on the last government, which is fair enough, up to a point. Yet at the same time as Mr Cameron condemns deregulation of alcohol and gambling, we learn the extent to which his ministers, too, were lobbied by the alcohol industry… While Labour should shoulder some of the blame, the government needs to treat addiction to alcohol and gambling – often affecting the same people – as a national emergency.

Jane Merrick, Independent, 8 January

News in brief

Deadly drinking 

Vodka consumption is one of the main reasons why a quarter of Russian men die before the age of 55, according to a study of more than 150,000 people over the course of a decade by the Russian Cancer Research Centre, WHO and the University of Oxford. ‘Russian death rates have fluctuated wildly over the past 30 years as alcohol restrictions and social stability varied under presidents Gorbachev, Yeltsin, and Putin, and the main thing driving these wild fluctuations in death was vodka,’ said Professor Sir Richard Peto of Oxford University. Alcohol and mortality in Russia: prospective observational study of 151,000 adults at www.thelancet.com

Meth message

Although methamphetamine remains a ‘minor player’ on the European drug scene, it has the potential to cause ‘significant’ harm ‘even at a relatively low prevalence’, according to a new report from EMCDDA. While there are longer-term entrenched patterns of methamphetamine use in the Czech Republic and Slovakia, increased rates of use are also being reported in Germany, Latvia, Greece, Turkey and Cyprus, says Exploring methamphetamine trends in Europe. ‘New injection trends’ among groups of gay men in London and elsewhere (DDN, April 2013, page 6) is also a ‘phenomenon that requires close monitoring’, it states. Report at www.emcdda.europa.eu 

Home grown

More needs to be done to address the growing problem of domestic drug consumption in Afghanistan, according to UNODC. The country saw a record opium crop last year (DDN, December 2013, page 5) and now has more than a million opiate addicts, a ‘national tragedy’ according to UNODC executive director Yury Fedotov. ‘For too long the threats of illicit drugs, crime and corruption have been neglected in efforts to shore up the security and stability of Afghanistan,’ he said. ‘We need to ensure that these issues are made national priorities.’

Dry days

Nearly 17,500 people signed up for last month’s Dry January, says Alcohol Concern – four times as many as the previous year. ‘Many participants are telling us through social media that this month has been a life changing experience for them,’ said the charity’s director of campaigns, Emily Robinson. ‘They’ve had lightbulb moments about the way they drink and why. We’re incredibly proud to be able to help people make changes which we hope will have a lasting, positive impact for them.’

Poor performance

Actors pretending to be drunk were served in more than 80 per cent of bars targeted for test purchases, according to a new report from Liverpool John Moores University’s Centre for Public Health. ‘UK law preventing sales of alcohol to drunks is routinely broken in nightlife environ­ments,’ says the study, published in the Journal of Epidemiology and Community Health. jech.bmj.com

Improving picture

A new report from the AVA project aims to provide an updated picture of the number of women’s aid refuges in London that provide access for women who use drugs and alcohol or have mental health issues. A 2002 survey revealed that just 13 per cent provided automatic access, while a further 48 per cent said they ‘sometimes’ would. Using freedom of information requests, the report found that most boroughs now include some level of requirement to support women with drug and alcohol and/or mental health problems, with only two actively excluding them. The document wants to see clear policies on working with women with these needs, a more comprehensive approach to risk assessment, and training for all refuge staff involved in the assessment of referrals. Case by case: refuge provision in London for survivors of domestic violence who use alcohol and other drugs or have mental health problems at www.avaproject.org.uk

In harm’s way

Laws and policies and their ‘justificatory social constructions and stigmas’ are responsible for worsening avoidable harms around illicit drug use, according to a report from Youth RISE and INPUD. ‘Understandings of drug-related harm and effect within the context of a criminalising paradigm are predominantly moral’ – rather than empirical – says The harms of drug use: criminalisation, misinformation and stigma, which studies the ‘social, legal and linguistic’ contexts of drug use. Available at www.youthrise.org

Commissioning counsel

Public Health England is developing a national framework for commissioning HIV and sexual health services, the agency has announced. The aim is to provide local authorities, clinical commissioning groups and the NHS with practical advice and best practice examples. A draft document for consultation will be available in April, with the final resource due in the summer. www.gov.uk

Shake up at Drinkaware over industry links

Alcohol education charity Drinkaware has announced ‘radical’ changes to its governance arrangements and a number of new appointments, following an independent audit of its effectiveness. The industry-funded charity has long been the subject of criticism over its perceived lack of independence.

Drinkaware has published a formal response to the 2013 audit, which was overseen by Guy’s and St Thomas’ NHS Foundation Trust chair Sir Hugh Taylor. The audit was critical of the charity on a number of issues including lack of an evidence base – ‘both to inform what Drinkaware does and to evaluate how it does it’ – and perception of industry influence, ‘resulting in a suspicion that Drinkaware is not truly independent of the alcohol industry’. It also described ‘weak stakeholder engagement’, leaving the organisation isolated within the wider alcohol harm reduction community, and lack of clarity over its mission and purpose.

‘Drinkaware is seen by non-industry stakeholders as lacking independence from its funders, and some are sceptical that it truly wishes to encourage responsible drinking behaviours,’ said the audit document. ‘Industry stakeholders are aware that these perceptions exist and are frustrated that their efforts to meet their corporate social responsibility obligations are undermined by Drinkaware’s lack of credibility with the public health community.’

While recognising the ‘inevitable tensions’ facing an organisation ‘with the remit and funding base’ of Drinkaware, the report wanted to see ‘substantial changes’ to the way it operates – in terms of funding, governance model and the way it carries out its core activities. It called for a restructuring of the board to include more lay trustees and the development of more positive relationships with non-industry stakeholders and health organisations.

Drinkaware now states that ‘almost all of the auditors’ recommendations have been accepted and have either been implemented or are in progress’, including commissioning independent research to inform strategy, improved transparency and forging new relationships with the public health sector. It also says that, while trustees have approved changes to the organisation’s governance – including a smaller board with no specific quota of industry professionals – the audit ‘found no specific evidence of inappropriate influence’.

Former Department for Work and Pensions permanent secretary Sir Leigh Lewis has been appointed as the new chair, and there are also three new trustees. ‘The announcement of our formal response to last year’s audit and the major changes in the governance of Drinkaware represents its “coming of age”,’ said outgoing trust chair Derek Lewis. ‘The new board structure and governance arrangements represent best practice in not-for-profit organisations and will ensure that Drinkaware is equipped to play an increasing role in tackling alcohol harm in the UK.’

Independent audit panel chair Sir Hugh Taylor called the developments – in particular the new governance arrangements –‘very positive’.

Full response and audit report at drinkaware.co.uk

February 2014

February DDNIn this month’s issue of DDN… 

‘Much has changed since the early sixties when… local volunteers were encouraged to provide overnight accommodation in their own homes for those young clients who had nowhere to go.’

In February’s issue, Jo Palmieri looks back at 50 years of social action affecting the drug and alcohol field as Blenheim celebrates a milestone anniversary. 

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page.

PDF VersionMobile Version

Room at the table?

Creating recovery‘I will never make apologies for being emotive about something that affects us all,’ said Noreen Oliver MBE, opening Creating Recovery, The Recovery Group UK’s conference in London last month.

The conference’s strapline was ‘funding opportunities for building abstinence recovery communities’ and the politicians were there to tell us why ‘recovery’ now meant ‘drug free’.

‘It’s about getting people as far from drugs as we possibly can,’ said work and pensions secretary, Iain Duncan Smith. ‘It’s all about giving people a chance, but with the discipline and determination to move people into recovery.’

Rosanna O’Connor of Public Health England stressed that there continued to be ‘high ministerial interest’ in this agenda, but warned that drug treatment money was likely to be squeezed even further now its ‘quasi ringfence’ had been removed, with community care funding ‘a particular challenge’. A rehab survey had confirmed a solid basis for local authorities to continue investing in them, but holding LAs to account would be ‘slightly more difficult’.

‘These are challenging times with funding constraints and potential disinvestments. We all need to up our game,’ she said.

Lord Benjamin Mancroft, chair of the Addiction Recovery Foundation and a peer in the House of Lords for 27 years, who had beaten his own addiction, was unequivocal that recovery meant abstinence, and that those who disagreed did so because they did not understand.

‘The healthcare profession can’t cure addiction,’ he said. ‘Doctors do not understand addiction – it’s not in their radar.’ The problem, he said, was that 95 per cent of healthcare was provided by one organisation, the NHS, controlled by doctors. That organisation was ‘the most dangerous dealer in the world’, for prescription drugs.

‘After 30 years of very careful observation, I understand abstinence and substitute prescribing. But I have never met anyone who’s benefited from substitute prescribing for any but a very short length of time,’ he said.

Christian Guy, of the Centre for Social Justice, brought the discussion back to equality and giving ‘every person in the country the choices we would want for our families.’ We should all agree that people should be given the choice to get drug free and stay drug free, he said.

The climate was becoming tougher without money, with more than half of local authorities cutting money for rehab.

‘As much as we hate to believe it, politics does matter,’ he said. ‘But it’s not just about money, it’s about lack of ambition for too many people in the system.’

We also needed to know what recovery looked like in later life, he said, as this group were in danger of being forgotten and written off, with the attitude ‘keep them quiet’ and ‘put them in shooting galleries where the rest of us can’t see them.’

With ‘more people in rehab for alcohol than drugs’, we were also not good enough at treating the root causes of the 1.6m people trapped in alcohol addiction.

‘Rehab is a chance to live again and surely that’s what recovery is about,’ he added. ‘Let’s go out with renewed determination to finish the job and give people that chance.’

Camila Batmanghelidjh, founder of Kids Company, warned of the need to ‘stop simplistic narratives of blame’ that were affecting children and young people. Of the 36,000 young people, children and vulnerable adults KidsCo supported every year, 81 per cent arrived addicted to drugs and 90 per cent of them had been introduced to drugs by their immediate carers.

‘Potentially, this country it sitting on an emotional and public health timebomb in the way that it’s not paying attention to the urgency of care for the most vulnerable,’ she said. ‘We should be thinking about the emotional health and practical living circumstances of our children.

‘We tend to think about recovery across the whole spectrum in “siloed” ways, but often people’s difficulties are complex and multiple and they have continuous challenges as they go through their recovery programme.’


Creating recoveryAgainst this backdrop of political, strategic and economic anxiety, there was a strong message of optimism and a proactive climate in the audience, many of whom had come to demonstrate their active recovery. ‘There’s a hell of a lot of power in the room – share what you’ve got,’ urged Noreen Oliver.

‘Whenever someone in the public eye talks of their recovery, it inspires others to do the same,’ said Chip Somers, chief executive of Focus 12, as he introduced former client Russell Brand (whose large white German Shepherd dog leapt onto the speakers’ desk, much to Rosanna O’Connor’s surprise).

‘I want this message of abstinence-based recovery to reach everybody,’ said Brand. ‘Addiction seems like such a hopeless condition when you’re using. Because of support from other addicts I’ve got a chance.’

The only way to get people to ‘stay clean’ was through support and a sense of purposefulness and togetherness. There was still demonisation of a section of society, but ‘till we have a compassionate approach we won’t solve the problem,’ he said.

Stuart Honor of The Basement Recovery Project (TBRP) demonstrated the power of ‘social contagion’ in creating recovery communities. ‘We are stronger in shoals,’ he said. ‘The number of people in your network correlates with personal and social recovery capital.’

TBRP’s recovery community centres gave opportunities to create long-term pathways, and the graduates – ‘community builders’ – thrived on giving peer support. ‘Visible change happens when we harness strength in the community,’ he said. Abstinence was just a necessary part of this process: ‘You have to turn off the water to mend the plumbing.’

Kevin Kennedy – Curly Watts from Coronation Street – echoed this view of recovery in sharing his story. As his acting career had begun to rise, so did his drinking – ‘I drank because I liked it. I enjoyed the pub, the camaraderie – until it all went wrong.

‘In 1997 I thought I’d discovered the secret of the universe – the morning drink,’ he said. After being sent by Granada to rehab, he began attending AA meetings ‘because I thought I was being watched by the press’. But he learned to love the ‘humble scout hut’ because it was keeping him well.

‘This is a shame-based illness – the only way out of it is abstinence,’ he said. While on holiday he visited a dry bar and came home determined to set one up in his home town of Brighton. ‘What better way to show off we’re in recovery,’ he said. ‘It’s important we change people’s view of what recovery’s about.’

Having an acceptance of the recovery culture was ‘crucial’ in prisons, said RAPt’s chief executive, Mike Trace. RAPt’s answer to building recovery communities was to have large peer networks, he said, supporting people to make the emotional changes that helped them to make progress. ‘The “what happens next?” is our biggest headache,’ he said – making sure they had recovery capital in good quality accommodation, friendship networks and employment prospects.

Russell Brand, RAPt’s newest patron, underlined the need for mutual support.

‘There’s a currency of kindness,’ he said. ‘We only stay well by helping other people to stay well.

‘Abstinence-based recovery is bloody hard,’ he added. ‘We’re all in this together.’

Russel BrandThe other important element of the conference was to look at funding opportunities, including the Give It Up Fund, launched by Russell Brand and managed by Comic Relief.

Gilly Green of Comic Relief explained that with £500,000 raised to date, the fund aimed ‘to promote abstinence-based recovery, increase access to treatment, help sustain long-term recovery and reduce stigma towards those with addictions.’

Applicants could present a clear vision for a recovery community, using effective local partnerships, for a grant of up to £70,000, or could apply for the small grants programme, which would fund smaller activities with up to £5,000.

Further opportunities were offered by Dominic Ruffy of the Amy Winehouse Foundation, who said their organisation – already involved in a schools programme in partnership with Addaction – could offer grants for projects on recovery.

‘Be creative,’ said Noreen Oliver. ‘Think of all the things out there built by service users. Work with agencies in partnership, tap into community assets.’

Carl Cundall of Sheffield Alcohol Support Services (SASS) had an encouraging message for those who thought a drug-using or dealing past might blight their opportunities. You have a CV of transferable skills, he said, such as excellent networking and problem-solving, being highly motivated and being able to manage people effectively.

That was one of the many benefits of recovery, he said – ‘it gives you the opportunity to watch people transform their lives.’ 

Photos by Simon Brandon, courtesy of RAPt.

 

On the frontline

Mat Southwell
Mat Southwell

‘I didn’t know that wasn’t what you were meant to do in the drugs field,’ says Mat Southwell of the participative approach he adopted when he first started working in the sector. ‘It was what I’d learned, so when I came to London I just automatically worked with people in the same way.’

An early HIV worker in the late 1980s, his introduction to the field was volunteering for an HIV centre and helpline established by the gay community in Brighton. He moved to London to work as an HIV counsellor and went on to become professional head of service for East London and City Drug Services, an organisation he’d helped to build up.

‘That participative approach was also partly because I didn’t really know very much about methadone and that sort of stuff – that wasn’t my background in drugs, so I had to ask people,’ he says. ‘So there was partly a pragmatism to my participative model and partly a philosophical commitment, but it opened up a whole array of different work that allowed us to constantly respond to new drug trends and issues, because we were working with people on the frontline of the east London drug scene which was where many of the new trends hit.’

He also developed the showcase Healthy Options Team (HOT), which ‘really gave me the credibility in the field’, he says. ‘It was what I brought from working with the gay men’s organisation where my director was a gay man living with HIV who was also a social worker, so I really got that model of community organising. This is where I started to get involved in championing responses to issues like HCV prevention and injecting, crack, heroin chasing, dance drugs and, most recently, ketamine.’ 


 

Although his career in the field has in many ways been defined by the struggle for the human rights of people who use drugs, for the first ten years it was defined by their health, he stresses. ‘In that acute period of the UK’s HIV epidemic we saw 60 people die of HIV when we cared for them in east London. The consequences of that public health crisis were very real for us. We really felt we were fighting to stop our community from being decimated.’

Despite being an activist deeply opposed to Margaret Thatcher, the irony, he says, was ‘living through an era where she created an environment that we could do work in that was incredibly innovative and very pragmatic, involving drug users, building collaborations with GPs and moving away from the traditional addiction model. We did some amazing work, and services really flourished.’

At that point he wasn’t publicly known as a drug user – although he was employing several people who were – but by the end of the 1990s he’d decided it would be more beneficial to ‘stand publicly’ as someone who used drugs. ‘The problem is that it’s always the people on the margins who are forced out into the open because of health or legal or other issues, and I wanted to make a choice to politically stand in solidarity with those people and fight alongside them,’ he says. ‘Of course when health crises arise we have to respond to them but we wouldn’t be in this health crisis – at least not so deeply – if it wasn’t for the stigma and discrimination and criminalisation.’

Although the NTA period that followed meant new investment, it also brought ‘stifling bureaucracy’, he feels, ‘and this fear of actually talking about what works. And we’ve now crashed into this recovery period which is fundamentally ideologically based. The irony for me as a global advocate is that I go around the world teaching people as a technical support provider how to do the British model while we reverse away from it as rapidly as we possibly can. I really worry about what the implications of that will be.’

The UK is ‘naïve’ if it feels insulated from major problems with HIV and other blood-borne viruses, he believes. ‘There was a second spike in the HIV epidemic here that coincided with crack arriving, and it was only really because we had good harm reduction and treatment services in place that it didn’t become a more fully fledged epidemic. We could get an outbreak linked to legal high injecting, for example, and we’d be very ill-equipped to deal with it. What seems like a trickle of a problem to start with can suddenly become a really big problem if you don’t manage it. And I fear that we don’t have the harm reduction infrastructure that we used to – the lack of fixed site needle exchanges is quite shocking.’

He’s also involved in HIV issues on a global scale, working as the International Drug Policy Consortium’s (IDPC) drugs and HIV consultant, a role that focuses on advocacy between drugs civil society and the United Nations Office on Drugs and Crime’s (UNODC) HIV team. Does he get the impression that the UNODC is beginning to open up a little more, after years of what many people perceived as intransigency?

‘In the last year or so we have seen an opening up, whereas historically UNODC was very reluctant to talk to civil society,’ he says. ‘Through some robust advocacy from civil society we’ve managed to force an engagement. There were discussions around the selection of which countries UNODC would be working in and what the priorities for those countries would be and civil society took part in that conversation. Are we 100 per cent listened to? Absolutely not. Do we have fully aligned positions? Absolutely not. But at least we’re talking to and working with each other, which is a huge step forward.’

A lot of people worried when Yury Fedotov took over as UNODC head (DDN, 19 July, page 5), but he hasn’t proved to be as hardline as many feared. ‘I think the thing to remember about Fedotov is that he’s a skilled diplomat – he understands how to manage the system. I wouldn’t be naïve around him, but I think the neglect of the drugs and HIV agenda up until about a year ago was causing such concern – not just within civil society but also with UNAIDS and other UN partners – that it just became unsustainable.’

Part of the initial worry about Fedotov was that he was Russian, a notoriously hardline country when it comes to drugs policy, and with catastrophic consequences in terms of HIV (see news focus, page 6). ‘I think the climate is changing, with America shifting position and all the experiments around drug policy – the problem is the entrenchment in places like Russia, who seem to have a complete disregard for human life. People who use drugs are seen as part of that outsider group that are treated appallingly. They’re using scapegoating as a strategy, and drug users are one of the groups being scapegoated.’

The challenge is to maintain a watchdog function on Russia while at the same time trying to counteract the country’s influence on its neighbours, he believes. ‘You try to then get more progressive drug policy and harm reduction practice pushing in, and that’s where UNAIDS and UNODC have both said “let’s start focusing on priority countries so that we actually work in fewer countries but demonstrate how the work should be done.” By putting more resources into some countries you get case studies to show that you can shift the epidemic, which then hopefully drives more domestic funding.’


In terms of that international engagement, his latest venture is Coact, a technical support agency with nine consultants he’s running alongside business partner Tam Miller. ‘The aim is that we go around the world teaching people harm reduction, drug user organising and drug treatment. All of us are ex or current drug users but we also have a dual professional background in drugs or HIV so it’s very much this function of bridge building – as well as standing up for the drug user community I also hold onto my identity as a drugs worker very proudly. One of the things we’re trying to do is help build bridges so we can all work together more effectively.’

When it comes to working together, does he feel that some of the old barriers between recovery and harm reduction are finally starting to break down – are things a little less polarised? ‘I think there are figures on both sides of recovery and human rights/harm reduction who share views and are looking for points of connection and trying to collaborate,’ he says. ‘There’s a whole lot of people who are trying to respond very healthily. But I think there’s a smaller group of recovery people who are much more politicised and fighting a whole political agenda that has bugger all to do with science. I get frustrated when people claim that I’m being divisive by critiquing those people. For me it’s about saying that these people are denying our human rights.

‘When the government’s own evaluation of recovery says it doesn’t work then we’re saying, “back your claims up”,’ he continues. ‘Our claims around harm reduction and humane drug treatment are well evidenced. This is where I feel that the recovery movement at its worst moves into being something like a cross between an evangelical church and a National Socialism rally, where if you object then people say “you’re letting all us down by not agreeing” or “you’re in denial”. If that’s the level of debate then we move into a different type of engagement.’

Mat Southwell is partner in Coact and associate consultant, drugs and HIV, at IDPC.  www.co-act.info

How far have you come?

 How far have you come?With recovery now the dominant model for alcohol and drug treatment, commissioning and research in both England and Scotland, there is a clear need to have an accessible, simple-to-use method for mapping recovery achievements in and out of formal treatment. This article introduces the REC-CAP (short for recovery capital), a new instrument that provides frontline staff with an easy-to-complete assessment of a client’s recovery functioning, and can become a useful component of recovery-oriented care planning. In addition to locating the client within a recovery framework, it will also provide an organisation with objective measures of changes and gains made by recoverees during and after formal treatment.  

In both Scotland (Scottish Government, 2007) and England (Home Office, 2008), public policy has seen a radical shift in focus and emphasis away from drug and alcohol interventions targeting crime and blood-borne disease to a more optimistic model based on individual wellbeing, quality of life and active engagement in the community. This transition to a recovery approach echoes the evidence from the mental health field where recovery has been shown to be characterised by a clutch of linked characteristics – connectedness, hope, identity, meaning and empowerment (collectively, CHIME; Leamy et al, 2011).

While the transition to a recovery model has provided much-needed hope and belief to addiction professionals, policymakers, family members and those with addiction problems, it also provokes a significant challenge for the science of addiction, around the measurement of success. Although there are a number of tried and tested outcome measures – the Addiction Severity Index (ASI) and the Maudsley Addiction Profile (MAP) to name but two – they have both emerged out of a pathology model where the aim of treatment has been the reduction of acute symptoms and adverse life consequences. They are not suited to the measurement of a growth of wellbeing and positive achievements as would be needed to track a recovery journey. What the REC-CAP does is to address this omission and so create a measure of growth that can continue long after acute treatment needs have been addressed, and which measures wellbeing and engagement in society. 

Recovery capital

The key to this dilemma is addressed in an article by White and Cloud (2008) who concluded that long-term recovery is much better predicted on the basis of strengths than on the management and reduction of pathology symptoms. This builds on work previously done by Granfield and Cloud (2001) who used the term ‘recovery capital’ for the first time to refer to the resources available to an individual to support their recovery journey. Elaborating on this, Best and Laudet (2010) categorised recovery capital as containing three dimensions:

•            Personal recovery capital represents the skills, capabilities and resources a person has that includes such things as self-esteem, resilience and communication skills.

•            Social recovery capital is the central component of recovery capital and includes the level of social support the person has, a network of support for their recovery and their commitment to and engagement with the support network.

•            Community recovery capital is the resources available in the community, consisting of the quality of treatment services, but crucially the availability and attractiveness of recovery communities and champions.

The three levels of recovery capital are assumed to exist in a complex and interactive dynamic, where improvements in one area have positive knock-on effects in the others.

However, much of the work on recovery capital in the addictions field has been largely theoretical and it was really with the production of a measure that this changed. One of the authors of this article, along with William White, a research consultant for Chestnut Health Systems and a leading recovery figure in the US, and Teodora Groshkova from the Institute of Psychiatry, worked together to produce the Assessment of Recovery Capital (ARC: Groshkova, Best and White, 2012). This is a validated and accepted research tool currently used in a number of countries that measures personal and social recovery capital, and which has been shown to be associated with positive treatment outcomes (Best et al, in preparation).

So what is the REC-CAP?

We have taken elements of four established engagement, outcome and recovery measures to create a flexible online recovery mapping measure that can be linked to both care planning and review, and to recovery management outside of treatment services. The four elements are:

•            Basic recovery enablers: Measures of key life issues mapped using elements of the Treatment Outcome Profile (TOP). These are not regarded as elements of recovery capital (and so are not shown in the REC-CAP star) but are seen as key issues to address to facilitate the recovery journey.

•            Treatment motivation and engagement: Measuring desire for help and treatment engagement for those in treatment using the Client Evaluation of Self and Treatment (CEST).

•            Recovery capital: Divided into separate sub-scales for personal and social recovery capital, and measured using the Assessment of Recovery Capital (ARC).

•            Recovery community engagement: Involvement in social groups supportive of recovery, assessed on the Recovery Group Participation Scale (RGPS).

These combine into five measures that are all scored out of 20 – treatment motivation, treatment engagement, personal recovery capital, social recovery capital, and community recovery capital.

Entering the scores creates a visual map of recovery wellbeing as shown in the accompanying illustration.

What is unique about the REC-CAP is that it is entered online and will automatically populate the graph above – initially to show how the person compares to other clients from that service – and so identify what strengths and resources they have for their recovery journey. However, in all review completions of the REC-CAP, the graph will show their own change in wellbeing, providing the person in recovery (and the worker) with a measure of growth in recovery capital.

Being a mapping system that is completed online, there is no paperwork, no data to be entered by harassed admin staff and no delays between completing the form (the initial form takes around 30 minutes and the review less than 10) and observing the scores. The online system is structured so that the results are available as soon as the last question is answered. This is a recovery outcome system that is flexible and easy to use, and one that minimises the burden on staff and on clients. We are currently exploring ways in which it can be linked to services’ existing databases. 

As a result, it has real application as a clinical recovery tool – where the worker and client complete the REC-CAP in a treatment session, they have immediate access to the results in the form of a graph or a printout of the scales. It provides immediate feedback on strengths and gaps, representing a genuine commitment to partnership recovery working for agencies and their clients. The REC-CAP is basically a client-level assessment that is collaborative and shared in supporting and developing recovery journeys and pathways, but it can also be used as a performance management measure in services to assess progress in enabling clients’ recovery journeys.

The REC-CAP system is now up and running, with a full worker manual and training pack and an IT support system in place to enable its immediate application either in DAATs or agencies.

Looking to partner

We are looking for agencies to partner with us in testing the REC-CAP, which is based on reliable and valid measures of wellbeing and recovery. It would provide an agency with an opportunity to pioneer an innovative recovery oriented approach to client management and to work in collaboration with us.

 The REC-CAP is unique – it is one of the first tools that will help to maximise the recovery potential of clients and introduce an evidence-based recovery assessment into the care planning of clients that starts but does not end with formal treatment. If you would like more details on the REC-CAP or would be interested in working with us as an early adopter of the REC-CAP tool, please do not hesitate to contact us at info@actrecovery.co.uk.

David Best, is director, ACT Recovery; head of research and workforce development, Turning Point, Melbourne and associate professor of addiction studies, Monash University. Tracy Beswick is director of operations and Merce Morell is director of resource management at ACT Recovery, www.actrecovery.co.uk

London calling

 

Blenheim Timeline
Click for larger image

This year Blenheim, one of the UK’s leading substance misuse charities, celebrates 50 years of delivering drug and alcohol treatment services across London. Blenheim is the successful merger of three organisations – The Blenheim Project, established in 1964, CDP (Community Drug Project) established in 1968 and CASA (Camden Alcoholics’ Support Association), established in 1977.

Much has changed since the early sixties when The Blenheim Project was first working with young ‘drifters’, drawn to west London for empathy and shelter. Back then, local volunteers were encouraged to provide overnight accommodation in their own homes for those young clients who had nowhere to go. Eighty per cent of clients were under the age of 30 and most of the young people who attended The Blenheim Project were uncertain in what they wanted, half-convinced that they would remain drifters, simply seeking a hot cup of tea and the clothing and luggage store. It was a challenging time for the professionals too.

‘I am not sure that we really knew what we were doing when we set up the Community Drug Project,’ says Gerry Stimson, now director of Knowledge Action Change. ‘What we did know for certain was that there was an increasing number of people in the area who were injecting drugs, and problems connected with drug injecting in and around Camberwell Green.’

Individually the three organisations were known for their ‘caring, compassionate and tolerant’ approach by the local communities and the professionals who supported and funded their work. Across the decades they have also been recognised for their innovation and responsiveness to local need – CDP was the only agency still running an injecting room in the ’70s, CASA delivered the first specialist services for the older drinker in the ’80s and The Blenheim Project opened the UK’s first crack day programme in the ’90s.

Blenheim is now one of the fastest growing charities in the UK, supporting over 9,000 people a year across London. 

Its staff are not only recognised for their professionalism in delivering recovery treatment services but also for their commitment to campaigning and influencing policy, as highlighted last week by Baroness Hayter in the first of their 50th celebratory events, at the House of Lords.

CDP

‘For 50 years Blenheim, CDP and CASA have been proactive social change organisations, rooted in the day to day challenges facing those with alcohol and drug problems, their families and local communities,’ she said. ‘As Blenheim enters their 50th year of social action they are committed to continuing to be a loud advocate for those with the most complex needs in society today. Campaigning and advising the main decision makers is indeed a key and significant part of Blenheim’s work.’                     

The celebratory event was attended by renowned professionals in the field, service users, commissioners and supporters. Speakers included minister for crime prevention, Norman Baker, who acknowledged there was more to do in tackling psychoactive substances and recognised the impact of alcohol use:

‘We will continue to challenge the alcohol industry to raise its game,’ he said. Blenheim’s CEO John Jolly responded that Blenheim would ‘continue to act as a critical friend’ to government.

Blenheim also chose this celebratory event to launch London Calling: Voices from 50 years of Social Action, a book which not only tells the history of Blenheim through thevoices of those who have been involved since the sixties, but also the story of the development of the drug and alcohol sector in the UK.

Blenheim‘It’s the story of how, together, we built the best drug and alcohol treatment system in the world, set within its historical and political context over the last 50 years,’ said Jolly.‘It is a celebration of the commitment of the thousands of people who have given their time, skills and energy to help those struggling with drugs and alcohol problems over the past five decades.’

A constant over the 50 years has been Blenheim’s commitment to listening and responding to service users. Tim Sampey, a former Blenheim service user and now chief operating officer of Build on Belief (BoB), is also featured in the book. BoB runs the largest peer-led weekend service in London and is now an independent service user charity.

‘Without Blenheim’s willingness to support something untried, without their courage to agree to our total independence and without their patience to put up with our wild enthusiasm and occasional unorthodox ideas, there would have been no seven-day-a-week provision and no Build on Belief,’ said Sampey. ‘Blenheim has truly demonstrated what service user involvement can and should be.’

Jo Palmieri is former director of business, innovation and skills at Blenheim.

For more information about Blenheim’s services, to purchase a copy of London Calling or to become a Friend of Blenheim go to www.blenheimcdp.org.uk and www.blenheim50.wordpress.com

Tim Sampey will be speaking at Make it Happen!, the national service user involvement conference on 20 February.

 

 

Olympian struggle

With the Sochi Winter Olympics now on, the eyes of the world’s media are on Russia. In the run-up to the games, much of the press focused on the country’s legislation banning the ‘promotion’ of homosexuality and the rising levels of homophobic rhetoric and violence that followed, leading some people to call for a boycott of the games. Less has been written about the plight of another of the country’s marginalised groups, however. 

According to Harm Reduction International’s most recent Global state of harm reduction report, there are an estimated at 1.8m injecting drug users in Russia, more than 37 per cent of whom are infected with HIV, while opioid substitution therapy remains steadfastly unavailable.

‘The government thinks that the main threats to the country are gay propaganda and opioid substitution treatment (OST), things like that – that they contradict our traditional

Anya Sarang
Anya Sarang

values and we should oppose them,’ Anya Sarang of the Moscow-based Andrey Rylkov Foundation for Health and Social Justice tells DDN. ‘OST is still unavailable and government oppo­sition to it remains very vocal and strong.’

Given the weight of international evidence, how does the Russian government justify its position on OST? ‘Basically they say that it’s a bad idea to replace one drug with another, and that substitution therapy is not effective,’ she says. ‘The chief narcologist of Russia says we don’t need this therapy and instead they put a lot of effort into naltrexone programmes and all kinds of antagonist treatment. Naltrexone is much more expensive, but they say it’s the Russian way to treat addicts. But even these programmes are very few, and go in the face of clinical trials – if they are available they’re very expensive and so not many people can afford them.’ 

Although there are some harm reduction services operating in the country, they remain ‘politically marginalised’, says HRI, with national drug policy depicting needle and syringe exchange programmes as ‘a threat to effective drug control’. 

‘There are a few needle exchange programmes,’ says Sarang. ‘We managed to keep funding from the Global Fund [to fight AIDS, Tuberculosis and Malaria] for this, but I don’t even know how many of them are still working. Our organisation runs its own needle exchange, needle distribution programme and street outreach work in Moscow, but we get nothing from the Russian government – the funding comes from the Open Society Foundations, the Levi Strauss Foundation, people like that. It’s all private foundations, as well as some remaining money from the Global Fund project, but now Russia isn’t even taking the money from the Global Fund, so I don’t know how long that will keep running.’

In fact, the government’s antipathy towards harm reduction even extends to attempting to ban the Andrey Rylkov Foundation from publishing information about methadone on its website and passing an order to close down the site a couple of years ago, a move described as ‘totally unacceptable’ by Human Rights Watch (DDN, June 2012, page 5). ‘They still don’t like it,’ says Sarang. ‘We went to the national courts but they ruled in support of the Federal Drug Control Service that we cannot place any information on methadone on our website – even information from UN agencies like WHO or UNAIDS. It’s very oppositional to the international position on substitution treatment.’

Despite the harassment, however, the foundation manages to keep the site going, alongside its outreach and other work. ‘We just had to move the website hosting from a Russian provider to an American provider so we still keep all this information, but now they have a new internet law which basically allows Russian officials to block access to any site they don’t like. They haven’t done it to ours yet but it’s possible, and without any legal procedure. So I’m not sure how long we’ll be able to provide this.’

The consequences of the government’s policies are becoming increasingly stark, however. According to UNOWED, the Russian Federation, US and China account for almost Rakhmanovsky half of the people in the world who inject drugs and are living with HIV (21 per cent, 15 per cent and 10 per cent, respectively), while Russian health watchdog the Federal Surveillance Service for Consumer Rights and Human Welfare says that more than 54,000 new HIV cases were registered between January and September last year alone, up more than 7 per cent on the corresponding period in 2012.

Unsurprisingly, nearly 60 per cent of the new cases were the result of injecting drug use, and the Russian Federal AIDS Center states that the country now has the fastest-rising infection rates in the world.

The numbers are especially troubling given that HIV infection rates are falling in much of the rest of the world, with a 33 per cent drop overall since 2001 (DDN, October 2013, page 5). ‘They’re managing to control the numbers due to scaled up prevention efforts and access to treatment, but in Russia the numbers are still rising,’ she says. ‘The majority of people who are getting HIV are drug users and if you don’t have harm reduction programmes and needle exchange programmes then there’s no prevention.’

And as there are increasingly few prevalence studies being carried out among drug users it can be hard to even establish the real extent of the problem, she says. ‘Russia is so huge and it depends on the region. In Moscow the last estimates, around four years ago, were that HIV prevalence was below about 14 per cent, but the prevalence studies documented up to 75 per cent in the city of Biysk, in Altai Krai, and in Samara Oblast it was above 60 per cent. But I think the average number is still just under 40 per cent.’

Even the government’s claims that it is addressing HIV by providing medica­tion such as antiretrovirals to anyone who needs them should not be taken at face value, she says. ‘A couple of years ago I was interviewing a large number of drug users for a WHO project and we found that, to have adequate access to medication, the doctors were saying, “you should treat your HIV but before you start your medication you should do something about your drug use.” But because there is no access to substitution treat­ment, no rehabilitation centres, no help, people go away and they get lost and they come back only when they’re dying.

‘If you don’t provide adequate drug treatment then it’s impossible to treat people with HIV, so when the government says, “everybody who wants medication can get it”, it’s hypocrisy,’ she continues. ‘Theoretically it’s true but they’re not able to get through this labyrinth of bureaucratic procedures to start treatment, and they’re not able to even maintain their HIV treatment because they go into drug relapses.’

The figures for hepatitis C infection among people who inject drugs also make grim reading, standing at more than 70 per cent according to recent estimates. ‘In some places it’s even above that – approaching 90 per cent – and hep C treatment is not available in Russia at all,’ she says. ‘Or it’s avail­able, but only to the few people who can buy it – it’s very expensive – and even then not to drug users. With HIV at least some people have treatment, but with hep C it’s a really bad situation. 

One fundamental root of the problem is that, in Russia, people who use drugs have no human rights, she states. ‘If you take the national drug strategy there’s no mention of human rights, and even if we talk to human rights organisations in Russia they’re not really interested in drug users.’ And there’s no mention of harm reduction in the strategy either, presumably? ‘Harm reduction is mentioned, yes, but it’s mentioned as a threat. The strategy is based on the principle that there should be a zero tolerance approach.’

Given how isolated the Russian government’s position has become, is there anything that the international community could realistically be doing to put pressure on them? ‘I Moscowdon’t know if it’s even possible to influence them,’ she says. ‘They have a strong standpoint in the international arena, they are very powerful and basically they can do whatever they want. Even at the high-level UN meetings on human rights they present substitution treatment as a threat. The government’s position is basically that everyone in the world is wrong, and they are right and that they should use this strong repression and base policy on zero tolerance with no regards to human rights or the health of people. This position is not changing, and there’s no flexibility.’

One thing she would like to see that could potentially make a difference, however, is for western clinicians to stop engaging with medical and clinical trials in the country, she states. ‘If would be good if they didn’t give health officials and drug treatment officials the money for these trials for antagonist treatments, for example.

‘American researchers come to Russia with their clinical trials because no one’s really interested in naltrexone in the US. They pilot their studies, the Russians receive huge funding and then the Russian officials present it as the Russian way of treating drug addiction, as some kind of miracle treatment. Of course everybody understands that it’s nonsense. OK, it’s one medication option, but it’s never been the most effective, and even if they do the clinical trials of new preparations they should compare them to the gold standard addiction treatment, which is substitution. So it’s not very ethical to do this in Russia.’

As well as providing more grounds for the Russian government to oppose substitution treatment, the main motivation is ‘basically economic’, she stresses. ‘It’s a very corrupt public health policy. If they’re being fed by their colleagues from the US and wherever with this clinical trials money, and they’re selling this expensive, not very effective medication, then of course they’ll keep doing it. So it would be good if at least on a professional level there was a change of position from the western researchers using Russia for this purpose.’ 

en.rylkov-fond.org

Tender opportunity for the Isle of Wight

Picture 3

TENDER OPPORTUNITY:

Invitation to Tender for the Provision of Recovery Focused Integrated Substance Misuse Community Services for the Isle of Wight

The Isle of Wight Council invites tenders from suitably qualified organisations for the provision of Recovery Focused Integrated Substance Misuse Community Services for the Isle of Wight. The contract is to run from 1 October 2014 for a period of 3 years with the option to extend for a further period of up to 2 years at the sole discretion of the Council.

Tenderers should be able to demonstrate the knowledge, innovation and ability to deliver substance misuse services to meet the needs of our local population. This will include adult, young persons and criminal justice services.

This service will be outcome focused and will deliver a recovery based journey through treatment. The contract will have a payment by result element. The expected allocated budget for these services is in the range of £1.2 to £1.4 million per annum.

It is intended to hold a Bidders Event on 7 March 2014 at the Council offices on the Isle of Wight subject to interest. The aims of this event are to explain,

• The service that we wish to commission

• What we are looking for from interested parties

• The calculation method for Payment by Results

• How the bids will be evaluated.

A more detailed advert can be viewed at: www.iwight.com/contractopportunities

Tenders can be submitted by completing a Tender pack which is to be returned by no later than 14:00 Hrs on the 31 March 2014.

The tender reference is PH/1305/T01 and the pack can be obtained from:

Email: lucy.mclaughlin@iow.gov.uk

Oxfordshire County Council (CPU785)

oxcc

THE PROVISION OF A LOCAL RESIDENTIAL DETOXIFICATION PROJECT FOR ADULTS WITH PROBLEMATIC SUBSTANCE MISUSE

Oxfordshire County Council Public Health Directorate are seeking expressions of interest from organisations interested in providing a medically assisted Residential Detoxification Project for adults, aged 18 years or over, with problematic drug and or alcohol addiction resident in Oxfordshire from a facility located in Oxford city.  These premises are managed under a separate agreement by St Mungos.

The project will provide 10 beds and will be a clinically managed residential detoxification service providing an intensive treatment programme that combines medically assisted withdrawal/detoxification and evidenced based psychosocial individual and group interventions.  The service will offer a programme for a maximum of 12 weeks with flexibility for intensive shorter stay, assisted withdrawal programmes of 4 to 8 weeks for those who are assessed as suitable.

Embedded within the medical detoxification plan and psychosocial interventions will be a 7 day programme of activities and positive healthy lifestyle programme, to meet the goals identified with the service user during the assessment and the care planning process.

This contract may also include support services for a 5 bed move on accommodation.

It is expected that the Contract will commence on 1 October 2014, and will be for a period of 3 years, with possible extensions of 1 year plus 1 year. Please note TUPE will apply to this contract.

Please express your interest via the “opportunities” function on the southeast business portal www.businessportal.southeastiep.gov.uk.

Oxfordshire County Council will not be bound to award any contract under this tender process. 

Tender documents will be issued to all interested parties at a later date.  If, however, you have any general questions regarding this service please contact Sarah Roberts, email sarah.roberts@oxfordshire.gov.uk

 

Make It Happen! programme

What’s on the programme

9.00am-10.00am: Registration and refreshments

10.00am-11.15am: Opening session.

Welcome – Neil Hunt sets the scene with a call for direct action.

Members of DISC’s peer-led Recovery Community, BRIC, tell how they’ve created The Hub, a safe environment in which people can develop their life skills, practical skills and confidence.

Sophie Strachan talks from first-hand experience about drug use and HIV, and brings a wealth of advice from her work with Positively UK in prisons.

Members of the San Patrignano community in Italy share their inspiring story. For the past 30 years the community has welcomed young men and women with serious problems linked to drug addiction completely free of charge, and without any discrimination. Now home to about 1,300 people, the community helps its residents to change their lives for the better through study, learning a trade and becoming active members of society.

 11.15am-11.45am: Refreshments

 11.45am-12.45pm: Challenges to ‘making it happen’ – a panel discussion with audience participation, chaired by Alex Boyt, service user coordinator.

Panel: Dr Judith Yates, GP; Kirstie Douse, Release; Anna Millington; Pete Burkinshaw, PHE; Bob Campbell, Phoenix Futures.

12.45pm-1.45pm: Lunch

Band and entertainment, exhibition including the service user groups, harm reduction café, head and shoulder massages, taster sessions on auricular acupuncture, yoga class, film show, photo booth (all day).

1.45pm-3.00pm: ‘Perspectives’, chaired by Alistair Sinclair, UKRF

Naloxone – Nigel Brunsdon, Injecting Advice and HIT

Visible recovery – Lancashire User Forum (LUF)

Hep C van – Jim Conneely, Hepatitis C Trust

The case for drug consumption rooms – Philippe Bonnet, founder of the Independent Consortium on Drug Consumption Rooms

UK recovery communities – Lester Morse, East Coast Recovery

3.00pm-4.00pm: Final session, chaired by Carole Sharma, FDAP

Over to the audience: ‘How have you made it happen?’

Tell us how you have overcome obstacles to make positive change happen for yourself or others.

Final speaker: Tim Sampey, Build on Belief (BoB), a charity set up by SUs, on how they made it happen.

 

 

 

New horizons

 AmarWe must challenge employers who don’t acknowledge the value of a second chance, says Amar Lodhia.

Over the past six months we’ve been changing here at TSBC. We’re transforming from a provider of training programmes to an organisation that still engages users through enterprise, but now in bespoke one-to-one sessions, embedded within a statutory or commissioned provision. We call this new model our Local Enterprise and Employability Service, or LEES for short.

One component of the new service is a work trial and job brokerage scheme that supports clients into short work placements with the aim of up-skilling them for their own ventures or supporting them into employment with small and medium-sized enterprises (SMEs), both locally and regionally. It’s clearly capturing the attention of the commissioners we’ve been speaking to.

Most people naturally understand an employer’s reticence about hiring someone with a criminal record or someone who’s battled an addiction. But where does this cosy understanding come from? Scratch away at this and you reveal a situation where no one is ever given a second chance or has the opportunity to make amends for past mistakes.

For me, the aim of recruitment is to find the person who best matches the skills, experience and personal qualities you need for the role. Excluding past offenders and those who have battled with addiction, you are, by definition, potentially missing out on the best match.

And when we talk of personal qualities, why would you not want to hire someone who has shown the resilience and fortitude to start their life over again? Time and again, we hear stories of how loyal people are to companies who’ve given them a second chance. At TSBC, one of our participants, whom we placed with a web developer, became their employee of the year that very same year – how’s that for paying back someone’s faith in you?

Of course, there are roles within financial services, so-called ‘controlled function’ roles, which have stipulations attached to them by the FCA. And yes, when the job involves unsupervised working with children or vulnerable adults, there’s a need to run a DBS (formerly CRB) check. But these account for only a fraction of all roles available.

I’m encouraged by the new Ban the Box campaign recently launched by charity Business in the Community (BITC) and supported by the likes of Alliance Boots PLC. The campaign aims to enable people with the highest barriers to employment to access work by challenging employers who use the blunt instrument of a tick-box exercise which is rejecting passionate, skilled employees – including those people who have received £300 fine for a driving offence!

It is troubling when I hear people saying that ‘that’s a graduate job’ or ‘that’s a very technical role’. This attitude simply fails to understand that addiction isn’t limited to just one layer of society, and that alcohol and drugs are no respecters of either intelligence or position. Once again, we need to urge employers to move beyond the preconceptions and consider each person on their merits.

We’ve recently come across an organisation trying to persuade employers to do just that. Clean Sheet are working to find employers who are willing to give offenders a fair chance, because they know that most ex-offenders do want to work.

As Anita Roddick told me over a cup of tea once – business must be a force for positive social change first and economic change will follow suit!

To enquire more about our work please contact me at amar@tsbccic.org.uk and follow me on Twitter @amarlodhia or @tsbclondon. Don’t forget to use the #tag DDNews when tweeting!

Amar Lodhia is chief executive of The Small Business Consultancy CIC (TSBC)

Recovery Festival booking form 2014

[contact-form-7 id=”7602″ title=”Recovery Festival Booking form 2014″]

United we stand

Jonathan MunroJonathan Munro tells DDN about the pioneering partnership working happening among prisons in the North East. 

The prison partnership is a new venture formed in April 2013, which brings together all substance misuse treatment providers in the North East under one single partnership umbrella. 

The partnership is made up of seven prison service establishments, NOMS, providers such as Care UK, Phoenix Futures, Lifeline and NECA – all coordinated by Addaction. The aim of the partnership is to provide an integrated team approach, both within prisons and also for prison transfers to the community, enabling a coordinated transition.

With a ‘partnership manager’ overseeing and coordinating the commissioned service providers, a truly collaborative treatment approach is being delivered with obvious benefits to service users.

Addaction were offered the opportunity to deliver the prison partnership model, because of their strong belief in partnership working. Although they had lots of experience of delivering in partnership, and had a community partnership model already located in the North East community, this venture was the first of its kind in prisons, both locally and nationally.

The North East is home to between 5,000 and 5,500 prisoners, a large proportion of whom have substance misuse issues. They are housed in a wide variety of prisons each of which, despite being very different establishments, has a Drug and Alcohol Recovery Team (DART) consisting of differing service providers offering both clinical and non-clinical interventions.

Overseen by Addaction partnership managers, the interventions are increasingly bespoke for the individual establishment, and consequently treatment is tailor-made for the service users rather than the off-the-shelf programmes so often offered in the past.

Lynn DouganThe recovery community in the North East is growing, and thanks to the innovative thinking of commissioners, the numbers are swelling inside prisons. There is a thriving recovery community emerging, with drug recovery wings, therapeutic communities and bespoke interventions. There are peer support, structured substance misuse and alcohol rolling programmes, as well as SMART, 12-step and NA/AA/CA all available.

In October 2013, an event launching a ‘partnership working agreement’ document took place in Durham City. The document places service users at its heart and details partnership working for substance misuse treatment within North East prisons.

The event heard from the likes of Gerv McGrath, the director of community services for Addaction, Professor John Podmore, a trustee of Addaction and ex-prison governor, and Mark Harrison, the commissioner responsible for the partnership management function in the community and instrumental in the introduction of the model to the prisons.

Delegates listened to ex-service users who had benefited from partnership working and who were now free from prison, drugs and crime as a result. They also got to ‘meet the team’ – the strategic partnership manager, Lynn Dougan and the partnership managers, all of whom have been appointed to individual prisons. Between us, we possess an eclectic range of backgrounds and experience, and we each spoke passionately about our new positions.

We aren’t naïve to the challenges facing us, but our camaraderie, enthusiasm and pride in our work made it clear to delegates exactly why this model of partnership working is proving successful in getting results in the challenging environments of North East prisons.

The partnership management function is driving forward the recovery agenda in the heart of the prisons and gaining the collaboration and respect of the respective prison establishments. Delegates heard about the work currently being undertaken in each prison and the exciting plans for the future.

The tagline at the bottom of each page of the partnership working agreement says it all: ‘Working together to deliver the best service possible to service users, their families and carers.’ It is clear the partnership management model of collaboration between different service providers is proving to be a success and drawing attention from across the UK – how long will it be before it’s rolled out beyond the North East of England?

Jonathan Munro is the partnership manager at HMP & YOI Low Newton.

Media savvy January 2014

Who’s been saying what..? DDN’s round-up of what’s being said in the national papers

The man who played the beloved sitcom character Chandler Bing, Matthew Perry, went head-to-head on Monday’s Newsnight with the man who plays maligned pantomime villain Peter Hitchens… Perry and Hitchens leading the national debate on drugs policy is the logical conclusion to most of the UK media’s reporting of anything medical or scientific; an end-of-days scenario that could only be improved if Matt Le Blanc stepped in for Perry, in character as sandwich-loving ladies’ man Joey Tribbiani.

Oscar Rickett, Guardian, 17 December

While I feel a wave of hatred beating against me whenever I walk into a BBC studio, it is never so strong as when I have come there to argue against the weakening of the drug laws. In fact they have pretty much stopped asking me to discuss this at all, since I dared to give a hard time to their favourite advocate of drug law relaxation, Professor David Nutt (how long before he gets his own show?). Drug abuse, you see, isn’t just a minor fringe activity. It is the secret vice of the whole British Establishment.

Peter Hitchens, Mail on Sunday, 1 December

The news that government advisers want ketamine reclassified from a class C to B drug is more fiddling while the crack pipe burns. The drug wasn’t banned until 2006, but someone who gets caught with it will now face up to five years in prison instead of two. A heavy price, one feels, for the person who wants to anaesthetise themselves of an evening. Send them to prison where drugs are the currency? It’s almost as if government advisers don’t live in the real world.

Suzanne Moore, Guardian, 11 December

Policies are not made in isolation… Law, economics, politics and public opinion are all important factors; scientific evidence is only part of the picture that a policy maker has to consider. Most of the major policy areas that consistently draw opprobrium from scientists are far more complicated than just scientific evidence: energy, drugs and health, to name just three.

Chris Tyler, Guardian, 2 December

Will I feel sorry for Nigella [Lawson] if these allegations – which she has denied – turn out to be true? Not really. Habitual and dangerous drug use can be sorted – if people want it to be.

Carole Malone, Sunday Mirror, 1 December

Until we get a government that is more concerned about the health of the population than that of the drinks industry, and an NHS prepared to tackle alcohol-related harm with the same vigour which with it tackles cardiac disease, we can only expect the problem to get much worse.

Dr Nick Sheron, Observer, 8 December

 I’m not a liberal on drugs policy and I don’t believe in legalisation: why make it easier for people to escape reality on yet more addictive, health-wrecking substances, when alcohol already triggers a crippling social and health burden our nation can hardly handle?… Yet we need to recognise, too, the deep and pervasive illogicality of our society – on almost every level – around questions of mood-altering substances.

Jenny McCartney, Telegraph, 7 December

Letters January 2014

LettersThe DDN letters page, where you can have your say.

The next issue of DDN will be out on 10 February — make sure you send letters and comments to claire@cjwellings.com by Wednesday 5 February to be included.

 

Claims rejected

We are writing in response to the letter from Stephen Keane in your last issue regarding alcohol treatment in the East Riding (DDN, December 2013, page 16). 

The NHS does not refer patients into the Alcohol Support Project East Yorkshire, though patients are at liberty to contact this organisation if they wish, as they could any other voluntary group. It is not the case that ‘there are no other support groups in most of East Yorkshire’. Apart from a large number of active groups run by Alcoholics Anonymous, the East Riding supports Humbercare, a locally contracted charity that provides support to service users, and provides mentoring training and opportunities to support drop-in services in the East Riding. Humbercare actively promotes and supports two groups that are open to clients with any form of addiction.

We would also take issue with the claim that a person referred to the alcohol aftercare service was told ‘They can’t take anyone else on for a few weeks.’ People who are referred to the alcohol aftercare service are always written to directly. In instances where there is a wait for a specific element of the service, support is always offered. Typically people are offered such support through the East Riding Direct Access Service, which is available at a wide variety of venues throughout the East Riding. Finally the reasons for Mr Keane being asked not to attend the treatment forum have been fully explained to him in writing, though he is, of course, at liberty not to agree with them. 

Tony Margetts, substance misuse manager, East Riding of Yorkshire; David Reade, involvement team leader, Humbercare; Victoria Coy, service manager addictions, Humber NHS Foundation Trust; Tim Young, chief executive, Alcohol and Drug Service

 

Route to recovery

I read DIP practitioner Jesse Fayle’s letter with interest (DDN, December 2013, page 16), but was disappointed to discover apparent support for the idea that ‘recovery’ has numerous meanings, instead of recognising that recovery from addiction falls into two main phases, the first of which is essential to achieving the second.

Dictionaries define recovery as ‘a return to a previous preferred superior state or standing’, and in respect of recovery from substance addiction this emerges as a return to the natural state of abstinence.

We then find other recovery steps resting on this foundation, which have together been perceived as ‘the recovery journey’ to what the majority of citizen’s consider a ‘normal life’ – recovery of responsibility, recovery from criminality and poor health, recovery of employment potential, of normal social relationships and of wellbeing and control of one’s life, etc.

There are also two classes of addicts – the 70 to 75 per cent who have regularly tried to kick their habit (often daily) yet, having failed, continue to try, and the other 25 to 30 per cent of restive cases who have no desire or intention whatsoever to quit for well-known reasons.

Those vested interests who wish to see the prescribing of addictive substances continue as the main treatment for drug addiction have, for their own reasons, placed emphasis on the recovery journey and on the 25 to 30 per cent of resistive cases, instead of on the return to lasting relaxed abstinence and the 70 to 75 per cent of addicts who want to quit their dependency but don’t know how and so need the opportunity to learn.

Resistive cases ‘who just don’t get it when it comes to embracing recovery’ may well be contenders for OST or naloxone, but the other 70 to 75 per cent have been proving for 48 years that they are enthusiastic and successful students when it comes to training to cure themselves and to achieving lasting abstinence.

Furthermore, such training results cost our taxpayers a fraction of what they pay for OST.

Kenneth Eckersley, CEO, Addiction Recovery Training Services (ARTS) 

Recovery rocks!

Recovery rocksA local partnership involving service users brought Nottingham’s first celebration of recovery and local music, as Lee Collingham reports.

As in recovery itself, many hurdles had to be overcome by Recovery Rocks, Nottingham’s first celebration of re­cov­ery and local music. There were issues with bands pulling out and venue availability, but in the end partnership working between two of the city’s local partners showcased local musical talent and celebrated recovery. SCUF, formerly the Shared Care User Forum and until Nottingham’s recent treat­ment recon­fig­uration, a user-led health campaign group, came together with Double Impact, an aftercare service and a partner in the new Recovery In Nottingham service, to make the event a success.

Having been involved in recent award-winning anti-stigma campaigns, SCUF members also took the opportunity to do some groundwork for their current campaign ‘Labels’, which will be presented at upcoming events as part of their continued work to highlight stigma and the effect it may have on someone’s treatment journey and mental health and wellbeing.

As experiences and research have shown, many people still don’t engage with treatment services or take full advantage of the support on offer for fear of being looked down upon or stigmatised – not only by people in treatment and healthcare but also by society in general.

A particular service or department can leave them feeling low and reluctant to engage because of how others see them. Often many other areas of their life are intertwined with their substance misuse or are a cause of it, such as mental health and homelessness.

Recovery Rocks aimed to raise funds to provide sleeping bags for those unfortunate enough to find themselves homeless in Nottingham over the festive period and also towards theRecoveryrocks start-up costs of SOBAR, Nottingham’s first alcohol-free bar, venue and restaurant.

Singer-songwriter Marc Reeves opened the evening’s proceedings, followed by a collection of artists including Sleeping Soldier and rock poet Miggy Angel, before the crowd were mesmerised by the melodic Rebecca King. Up-and-coming rock and blues artist John Lennon McCullagh, who recently signed to Alan McGee’s new record label 359, performed in front around 200 people and a raffle was held to raise further funds.

Feedback from the event was that it was an enjoyable evening and an excellent opportunity to raise awareness of addiction while highlighting harm reduction, with an alcohol-free bar upstairs as well as alcohol for those who wished to drink safely. This worked really well, with no reported incidents of drunkenness or trouble.

Following the success of this first event there are already discussions for it to become an annual event. The money raised after expenses has been split evenly between Double Impact and SCUF’s representatives the homeless team, to provide sleeping bags at a homeless breakfast event.

SCUF and Double Impact would like to express their gratitude to all those who helped organise the evening, the artists, and those who attended, for their support.

Lee Collingham is a service user activist in Nottingham

January 2014

January issueIn this month’s issue of DDN… 

‘What we have done is outsourced the responsibility to criminals, dealers, gangsters and drug-obsessed internet psychonauts for our drug policy…’

This issue, Max Daly reports from HIT’s Hot Topics conference, spotlighting changes in the drugs field. Also in the magazine, DDN hears how the Hepatitis C Trust’s testing van is taking services out on the road.

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page.

PDF Version/ Mobile Version

Injecting young people a ‘blind spot’

Injecting drug use among under-18s remains a global data ‘blind spot’, according to a report from Harm Reduction International (HRI).

Young people who inject drugs are ill-informed about the risks, less likely to access treatment and have ‘specific develop­mental, social and environmental vulnerabilities’, says Injecting drug use among under-18s: a snapshot of available data.

There is no global population size estimate for the number of under-18s who inject, says the document, while the legal status of being a minor also raises challenges in terms of developing targeted harm reduction interventions. ‘Too often younger drug users are “hidden in plain sight” – we know they are there but do not know enough about their needs and risks,’ says Greg Ramm of Save the Children in the report’s foreword. ‘This cannot continue.’

Injecting drug use among under-18s: a snapshot of available data at  www.ihra.net

Upgrade ketamine to class B, urges ACMD

Ketamine should be upgraded from a class C to class B drug, the Advisory Council on the Misuse of Drugs (ACMD) has recommended.

The recommendation follows increasing evidence of bladder damage caused by frequent use of the drug, says ACMD, as well as the growing numbers of people seeking treatment for ketamine-related problems – up from just over 100 to more than 800 in the five years to 2010/11.

The drug was controlled as class C in 2006, following a previous review by ACMD, with home secretary Theresa May telling the council in 2012 that a review of the latest evidence was ‘now warranted’ (DDN, April 2012, page 4).

Among the new report’s recommendations are that more is done to make people aware of the long-term physical risks of frequent use, as there is ‘currently no evidence-based ketamine education or prevention work being delivered in schools in the UK’, as well as awareness raising around how ‘the analgesic, anaesthetic and dissociative effects of ketamine can potentially make users vulnerable to robbery, assault and/or rape’.

The drug should also be considered as dependence-forming for some users, it says, and wants to see treatment services ‘able to respond to this need with NICE-recommended psychosocial interventions’. Healthcare practitioners – ‘particularly, but not just, GPs’ – should also be asking those presenting with unexplained urinary tract symptoms about ketamine use, it says.

‘The harm ketamine posed to users prompted the ACMD to recommend its control in 2004 – since then, we have seen evidence of a worrying trend of serious bladder damage occurring among frequent users,’ said ACMD chair Professor Sir Les Iversen. ‘It is a potentially dangerous drug at high doses and with frequent use, with serious psychological and physical implications for those who misuse it.’

DrugScope welcomed the review but said that reclassification would not be enough to address the public health problems associated with the drug. ‘Drug users, nightclub and festival staff and healthcare practitioners all need to be better informed about ketamine, its effects and potential for dependency,’ said director of communications and information, Harry Shapiro. ‘This is especially important in general health settings when people present with unexplained bladder problems.

The ACMD’s recovery committee has also published its second report, What recovery outcomes does the evidence tell us we can expect?, warning that drug recovery will be ‘a long battle’ for some.

Reports at www.gov.uk

Government launches ‘legal high’ review

The government is to review the laws relating to new psychoactive substances, the Home Office has announced, in a bid to ‘clamp down on the trade in potentially fatally drugs’.

The review will have input from ‘law enforcement, science, health and academia’ and study international and other evidence, with findings to be presented in the spring. It will then ‘make a clear recommendation for an effective and sustainable UK-wide legislative response’ to the new drugs, with options including ‘the expansion of legislation to ensure police and law enforcement agencies have better tailored powers’.

‘The coalition government is determined to clamp down on the reckless trade in so-called “legal highs”, which has tragically already claimed the lives of far too many young people in our country,’ said crime prevention minister Norman Baker. ‘Despite being marketed as legal alternatives to banned drugs, users cannot be sure of what they contain and the impact they will have on their health. Nor can they even be sure that they are legal. Our review will consider how current legislation can be better tailored to enable the police and law enforcement officers to combat this dangerous trade and ensure those involved in breaking the law are brought to justice.’

DrugScope said it ‘cautiously’ welcomed the review but added that legislation alone was not sufficient to address the problem. ‘This is an attempt by the Home Office to bolster current enforcement efforts and to see what other legislative options could be brought to bear on this new and complex drug situation,’ said outgoing chief executive Martin Barnes. ‘It is vital that education and information efforts are significantly enhanced in order to make the public – especially young people – more aware of the risks posed by experimenting with substances of unknown content and origin. These substances are not labelled ‘research chemicals’ by sellers for nothing.’

The Home Office has also announced that two groups of substances under a temporary banning order – NBOMe and Benzofuran compounds – will become class A and B drugs respectively, and has issued guidance to local authorities on the options available for addressing the issue of ‘head shops’ selling new psychoactive drugs.

Meanwhile, a report from the Home Affairs Committee has also called for improved education on new psychoactive substances in schools and colleges and states that the police and other law enforcement bodies have ‘failed to understand’ the impact of the new drugs. It wants to see legislation that shifts ‘the evidential responsibility’ of proving the safety of a substance onto the seller and also recommends that medical practices begin anonymous data collection to establish how many patients have become addicted to prescription drugs.

‘We are facing an epidemic of psychoactive substances in the UK with deaths increasing by 79 per cent in the last year,’ said committee chair Keith Vaz. ‘New versions of these “legal highs” are being produced at the rate of at least one a week, yet it has taken the government a year to produce five pages of guidance on the use of alternative legislation.’

Guidance for local authorities on taking action against head shops selling new psychoactive substances at www.gov.uk

Drugs: new psychoactive substances and prescription drugs at www.parliament.uk/business/committees/committees-a-z/commons-select/home-affairs-committee/

See here for a profile of new psychoactive drugs expert Dr John Ramsey

Fewer young people in treatment

Just over 20,000 under-18s received help for drug and alcohol problems in 2012-13, according to figures from Public Health England (PHE), down more than 600 from the previous year.

More than 13,500 sought help for cannabis as their main problem drug, and more than 4,700 for alcohol, while ‘historic low’ figures for young people needing help for heroin or cocaine – 175 and 245 respectively – were offset by increasing numbers having problems with amphetamines, mephedrone and other new psychoactive substances.

‘Young people’s alcohol and drug use is generally less established than adults’, so they tend to respond quickly and positively to interventions,’ says Substance misuse among young people in England 2012-13, with the average length of a treatment episode around five months.

‘While the overall picture on young people’s substance misuse is fairly positive, cannabis and alcohol still present real challenges and services are also having to adapt to cope with the consequences of increased use of club drugs and newer substances,’ said PHE’s director of alcohol and drugs, Rosanna O’Connor.

Meanwhile a report from Dr Foster found that people with a drug or alcohol problem accounted for almost 20 per cent of all emergency hospital admissions among the 40-44 age group. The latest figures from the Office for National Statistics (ONS), however, show that the proportion of adults who drank on at least five days of the previous week has fallen from 22 per cent to 14 per cent of men and from 13 per cent to 9 per cent of women, with the over-65s the group most likely to have drunk regularly. ‘People who drink frequently – every day or on most days of the week are just as likely as those who don’t drink as often to think they are in good health,’ said Drinkaware chief executive Elaine Hindal. ‘However, the medical evidence is clear; regularly drinking above the lower-risk alcohol guidelines increases the chances of developing health problems such as liver disease and cancer.’

Substance misuse among young people in England 2012-13 at www.gov.uk; myhospitalguide.drfosterintelligence.co.uk; Drinking habits amongst adults, 2012 at www.ons.gov.uk

‘Golden triangle’ opium production up 22 per cent

Opium production in the ‘Golden Triangle’ of Myanmar, Thailand and Laos rose by 22 per cent in 2013, according to the United Nations Office on Drugs and Crime (UNODC).

Production has now been increasing for seven consecutive years, says Southeast Asia opium survey 2013, and rose by more than 25 per cent in Myanmar, the world’s second largest grower of opium poppies after Afghanistan. ‘Villagers threatened with food insecurity and poverty need sustainable economic alternatives or they will continue, out of desperation, to grow opium as a cash crop,’ said UNODC Myanmar country manager Jason Eligh. Afghanistan also saw a record high opium crop in 2013, up by 36 per cent on the previous year as farmers attempt to ‘shore up their assets’ prior to this year’s planned withdrawal of international troops (DDN, December 2013, page 5).

Southeast Asia opium survey 2013 at www.unodc.org

News in brief

Green future

Transform has launched a new publication on regulating legal markets for non-medical use of cannabis. How to regulate cannabis: a practical guide looks at the challenges of developing and implementing an effective approach, with the regulation debate now firmly part of the mainstream according to co-author Steve Rolles. ‘With so many countries leading the way, it is likely that the rest of the world will follow within the next ten years,’ he said. Uruguay approved a bill to legalise the growing, sale and consumption of cannabis in December, with the law expected to come into force in the spring, a decision UNODC called ‘unfortunate’.

Available at www.tdpf.org.uk

 

Stark choices

US drug defendants are ‘routinely’ threatened with ‘extraordinarily severe’ prison sentences by prosecutors to make them plead guilty and waive their right to trial, according to report from Human Rights Watch. The average sentence for federal drug offenders who pled guilty was just under five and a half years compared to 16 years for those convicted after trial, the report found. ‘Prosecutors give drug defendants a so-called choice – in the most egregious cases, the choice can be to plead guilty to 10 years or risk life without parole by going to trial,’ said the report’s author Jamie Fellner. ‘This is coercion pure and simple.’

An offer you can’t refuse: how US federal prosecutors force drug defendants to plead guilty at www.hrw.org

 

The road ahead

The Home Office has published its second review of the drug strategy, highlighting the priorities of ‘reducing demand, restricting supply and building recovery’. Meanwhile, PHE has issued a new guide to reviewing treatment, based on supplementary evidence from Professor John Strang’s recovery-orientated drug treatment expert group.

Delivering within a new landscape and Medications in recovery: best practice in reviewing treatment at www.gov.uk

 

Life begins at 50

Substance misuse charity Blenheim is celebrating its 50th anniversary by releasing 50 first-person stories from people who have turned their lives around. A new story will be available every Monday throughout 2014 at www.blenheim50.wordpress.com

 

Deadly drinking

Alcohol-related mortality in Scotland was 80 per cent higher than in England and Wales in 2011, according to figures from NHS Health Scotland and the Glasgow Centre for Population Health. Around 23 per cent more alcohol than south of the border was sold in the country during the year. ‘We must tackle the toll that Scotland’s unhealthy relationship with alcohol is taking on our society,’ said health secretary Alex Neil.

A comparison of alcohol sales and alcohol-related mortality in Scotland and Northern England at www.healthscotland.com

 

Recovery cash

Recovery-orientated drug and alcohol treatment centres are set to receive £10m in new capital funding, PHE has announced. The money will be distributed via local authorities to NHS and voluntary sector providers, with all recovery-focused adult services eligible to bid. ‘We are delighted to announce this additional investment which will provide valuable support for ambitious and creative recovery-focused initiatives across the country,’ said director of alcohol and drugs, Rosanna O’Connor. The applications process will be managed via PHE’s regional centres, with awards to be announced in March 2014.

 

Access all areas

The government’s decision to abandon minimum unit pricing for alcohol was partly the result of the ‘extraordinary access granted to companies and industry groups by individual MPs and many government departments’, according to a report published in the BMJ, with 130 meetings taking place with lobbyists, few of which were publicly documented. 

www.bmj.com/content/348/bmj.f7646

 

Paul Goggins

Former drugs minister Paul Goggins has died aged 60, after collapsing while jogging. Labour leader Ed Miliband called him a ‘dignified, humane, wise and loyal’ politician.

 

Infections toolkit

A new toolkit on monitoring infectious diseases among people who inject drugs has been launched by EMCDDA, including study methods and example questionnaires as well as a comprehensive overview of the key issues. The organisation has also published a guide to the civil society organisations engaged in drug policy advocacy in Europe.

Drug-related infectious diseases and Drug policy advocacy organisations in Europe at www.emcdda.europa.eu

In it together

Rosanna o'connorA new set of resources to support access to mutual aid has been published by Public Health England. DDN reports.

Supportive peer relationships with people who’ve had similar experiences are acknowledged as a vital aspect of recovery from problem drug and alcohol use, and Public Health England (PHE) is keen to see the treatment sector strengthen its relationship with mutual aid organisations.

A new range of PHE resources aims to raise awareness of the benefits of mutual aid among commissioners, service managers and their staff; and make sure clients are taking full advantage of what’s available. As well as a keyworker guide to helping clients engage, there’s an audit tool to enable commissioners to determine local barriers to access, and a briefing on the evidence base for mutual aid’s role in supporting recovery, drawing together findings from previous key studies.

The resources were put together through extensive collaboration with mutual aid groups and providers over the course of a year, and PHE also plans to publish practical guides for commissioners and service managers in the spring. In the meantime, however, the mainstream treatment sector should be working to strengthen its relationships with mutual aid groups, the organisation urges.

‘What we would expect is that providers automatically have good engagement with mutual aid groups – however many there are in their locality – and well-developed pathways between formal treatment services and mutual aid,’ PHE’s director of alcohol and drugs, Rosanna O’Connor, tells DDN. This means that, rather than just knowing about the groups or giving out information, services should be ‘actively seeking to support people by making linkages with mutual aid, helping them to participate and sustaining interest’, she stresses. ‘So where people attend for the first time and maybe don’t particularly feel comfortable in that group, they can help them think again or help them look at alternatives, depending on what’s available.’

This is crucial, as accessing mutual aid meetings for the first time can be intimidating, she acknowledges. ‘For any of us, going to something that’s unusual and unknown can be like that. It’s important that it’s as comfortable and positive an experience as possible, so that initial interest has the potential to take off.’

Is awareness of the benefits of mutual aid still low? ‘I think it’s higher than it was because it’s been a priority that we’ve been pushing for over a year now,’ she says. ‘It’s been high on our agenda, although of course that’s been at a time of substantial change within the field. So it’s better than it was, if not as good as we’d like it to be.’

In the appendix to the keyworkers guide, there’s a series of handouts for clients that debunk some myths around mutual aid, such as the religious aspect in relation to 12-step fellowships. Are there are still a lot of misconceptions out there? ‘I think there are, and I think a number of us would own up to having had those in the past. There are those sort of cultural or ideological hurdles that some people feel they might have to overcome, but there are a variety of groups out there so if a good fit isn’t found immediately then it’s worth pursuing and looking elsewhere.’

While providers clearly need to be familiar with the philosophies of the different groups so they can point people in the right direction – and PHE has been working with some groups to help them in terms of how accessible they feel to newcomers – should keyworkers be attending meetings themselves to give them a better insight into what it would be like for their clients? ‘Whatever works in each locality – we don’t want to be prescriptive – but a level of awareness of what happens at these groups is good to have,’ she states.

Could mutual aid be one way of addressing regional variations in treatment outcomes?

‘Mutual aid is just one of the component parts of a successful treatment system, but it’s definitely something that we would expect to be in place. There’s good evidence that it’s effective – for example, the addition of just one abstinent person to a drinker’s social network increases the likelihood of abstinence in the following year by 27 per cent. That’s quite a remarkable statistic, so to me it would seem mad if every locality across the country wasn’t attempting to achieve that potential difference.’

One of the key challenges facing the sector now is the population of entrenched opiate users aged over 40. Is this a group where good quality peer support could potentially play a vital role?

‘You would think so,’ she says. ‘You can never predict who’s going to be successful and at what stage. Most of us will have seen people who we never imagined would survive going on to be very successful in terms of recovery, and service users will come across people like that in every mutual aid group or meeting they might go to. To be able to see people in recovery who they may well have known themselves as users, or who they know to have had very significant problems, is hugely empowering and gives people a vision of their own recovery. We have got a very challenging population in treatment now who we’re looking to help recover, so every little bit of the system that can be tweaked to improve recovery outcomes is what we’re after.

‘We’re talking about people whose social networks, as they still exist, have probably been part of the problem in the past and part of the challenge that they’re trying to overcome. So helping people to create new networks of social support is really important.’

Resources available free at:

www.nta.nhs.uk/mutualaidbriefing.aspx

www.nta.nhs.uk/Mutualaidselfassessment.aspx

www.nta.nhs.uk/MutualaidFAMA.aspx

or for more information contact: Miranda.Askew@phe.gov.uk

Open market

Max DalyHow easy is it to have any drug you want delivered to your door with no questions asked? This and other issues raised at HIT’s Hot Topics conference gave a revealing snapshot of changes in the drugs field, as Max Daly reports. 

The change that has been buffeting the drugs field for the last five years was neatly contained in two images shown at HIT’s latest Hot Topics conference, held in Liverpool in November. On the first slide, shown to a captivated audience at the Foundation for Art and Technology, appeared an encrypted message sent to an online drug dealer. It appeared as a stream of 500 or so random letters and numbers. Total gobbledygook in fact. The second slide was the same email before being encrypted. It simply read: ‘Dear XXX. Please can I order some heroin? I’d like three grammes to my house in London at this address.’

What investigative journalist Mike Power, the author of Drugs 2.0: The Web Revolution That’s Changing How the World Gets High was showing the audience was how easy it is, with a bit of online know-how, to order any drug you want on the internet and get it delivered, no questions asked, to your front door from anywhere in the world. No shady bedsits or risky street corner transactions, just a polite email requesting to be sent one of the most vilified substances on the planet.

Accompanied by other, highly fresh Hot Topics talks on naloxone, legal highs, club drugs, the drug trade, harm reduction, sex work, employing users and policing, Power’s presentation shed light on the world’s rapidly changing drug market, and with it, a whole new raft of problems for those working in the harm reduction sector.

By way of Colombia, Cambodia, Liverpool and China, he described how recent developments in the way drugs are produced, sold and consumed has led to him to deduce that regulation is the only sensible way of stemming the decades of ‘bloodshed’ created by the war on drugs.

What set him going on his investigation into the modern drug trade, he explained, was a story he covered in deepest Colombia in 2007, accompanying a UN-sponsored team whose job it was, backed with heavily armed Colombian soldiers, to destroy, field by field, as many coca plants as they could.

Power asked one of the coca farmers what he was going to do next in order to feed his family. The farmer explained that, economically, coca was the only feasible crop to grow. As soon as the soldiers had moved on, he’d start planting coca in the next field.

At the time, with cocaine use rocketing across much of the West, Power knew that what was happening in the Colombian field was indicative ofthe ‘relentless, circular, insane story’ of the drug war ‘that fascinated me’. Spin the globe and Power took us to the rainforests of Cambodia in 2008, where the UN scored a major strike in its battle to stop the production and trafficking of safrole oil, the major component of ecstasy pills. The huge seizure of the oil stopped an estimated 245m pills reaching the European market and resulted in a drought in good quality ecstasy.

This bust, he explained, created a gap in the market for a substitute, and mephedrone emerged to fill that gap. Mephedrone gained rapid popularity and acted as a catalyst for the modern online market in a new breed of psychoactive substances that we all know today.

But how easy exactly, Power wanted to know, was it to make your own drug? Power decided the best way of answering this question was to try and make one himself.

Which he did, using a phone, an internet connection and PO box. Within a few weeks Power has contacted a Chinese lab and ordered up a tweaked legal version of phenmetrazine, a now-banned slimming drug prescribed in its millions in the 1960s which also became a recreational drug of choice for The Beatles.

Encrypted message

The manufacturers sent him a chromatography rendering of the drug and offered to deliver it for free. As Power says, this ‘concierge drug design offered better customer service than Tesco’. When the packet arrived he got it tested and confirmed it was his own phenmetrazine hybrid.

But why would anyone bother doing this? Simple, said Power, who claimed he could quickly have made 50 times his original investment. ‘Given the right hype I could have been a millionaire within six months. Yes it was easy for me because I’m a drug journalist, but if you want to do it you can do it. It’s possible.’

So what does this all mean, asked Power. Well, he said, ‘you can ban drugs but you can’t ban chemistry.’ And this unstoppable chemical free for all, this ‘access with no barriers’ is proving deadly, as has been proven with the number of PMA-related deaths in the last six months.

‘Over the course of a century, a clear a pattern has emerged. As each law is made, a means to circumvent it is sought and it’s found. Those means can be chemical, legal, social or technological.’ Power said we stand at a crossroads formed by these four elements, with the web maximising communication and distribution.

‘What we have done is outsourced the responsibility to criminals, dealers, gangsters and drug-obsessed internet psychonauts for our drug policy. So I’d argue it’s time to change the drug laws that have failed to reduce demand or consumption and failed to reduce the proliferation and emergence of ever more dangerous drugs on our society. Even I can make them.’

Power relayed a neat drug war analogy given to him by Dr David Caldicott. ‘If you see drugs as an illness and prohibition as an antibiotic. If you treated any illness with the same antibiotic for 50 years, medical people would be astounded if a resistance had not developed.’ And that’s exactly what’s happened said Power. ‘The only reason legal highs exist is because of drugs laws – it’s a paradox.’ Power called for supply, distribution, purity and consumption to be controlled.

Coming back full circle to Colombia, Power said recent news about the FARC rebels planning to lay down their arms after 50 years of bitter civil Deciphered messagewar offered hope that the inertia on drug policy can be broken. ‘If the civil war in Colombia which has resulted in 50,000 deaths over 50 years can be negotiated to an end in my lifetime, I remain optimistic that we can overhaul our outdated drug laws and after 50 years of bloodshed, make peace.’

The raft of new highs now being peddled in head shops, by dealers and over the internet was also addressed by Dr Russell Newcombe of 3D Research. He has been keeping an eye on drug trends for the last 30 years. His presentation, aptly titled The Game Changer navigated a path through the jargon and myths around these often fly-by-night substances that continue to bewilder parents, journalists and drug workers alike.

Newcombe began by addressing terminology. ‘Legal highs’ includes drugs, new or old, such as nitrous oxide, that are not banned, while novel psychoactive substances (NPS) are new drugs that are either controlled, like mephedrone, or uncontrolled, as in the case of Power’s online Chinese creation.

He explained that the legal loophole used by shops and online retailers to get round the 1968 Medicines Act, by branding packets ‘Not for Human Consumption’, ensures that they are not classed as a medicine and therefore no tests or trials are required.

Although there is a plethora of chemicals out there, he said that most are synthetic cannabinoids, hallucinogens, stimulants or benzo-type drugs. In 2012 for example, 50 of the 73 new NPS drugs that appeared in Europe were synthetic cannabinoids, although Newcombe said these marijuana substitutes were farm from harmless, with one, XLR-11, causing kidney injuries.

These are not niche substances, said Newcombe. Four in ten young people responding to a survey by the music magazine NME said they had tried legal highs, while 12 per cent of respondents to the 2013 Global Drugs Survey had done so. Nitrous oxide, or laughing gas, is the most used of the legal high/NPS drugs despite the fact it has such a low profile in the media, in educational literature and in terms of research.

The web has acted as an enabler for the trade in NPS, added Newcombe. He said the number of detectable sites selling NPS across Europe had risen from 170 in 2010 to 690 in 2012, while the number of Google search results for the phrase ‘buy legal highs’ is now nearly seven million. But the downside to this innovation is that, for the drug buyer, the drug market now exists in a sea of chaos.

Newcombe said that buyers have little idea what they area getting or how dangerous it will be. Analysis of one ‘Rockstar’ ecstasy pill found it contained 11 different drugs. Moreover, these drugs are mutating. A packet containing two legal highs identified in Japan was found to contain a third drug that had been produced by an unexpected reaction between the original two drugs.

It’s certainly a game changer. Legal highs/NPS have expanded the drug menu beyond recognition and new drugs are created as quickly as existing ones are banned. This has resulted in a whole host of new harms that many drug services are unprepared to deal with.

The next move, suggested Newcombe, should be to use the knowledge of legal high/NPS users – the very people whose bodies are being used as human guinea pigs – to inform policy-making and drug services.

Slides and footage of HIT’s Hot Topics 2013 conference can be seen here: http://hithottopics.com/

Max Daly is the author of Narcomania: How Britain Got Hooked on Drugs

Hep van man

With hepatitis C still massively under-prioritised, DDN hears how The Hepatitis C Trust’s testing van is taking services out on the road.Jim

‘It probably adds up to a few months every year,’ says Hepatitis C Trust outreach officer Jim Conneely of the time he spends travelling the country in the trust’s testing van. ‘It’s exhausting but I enjoy it. When people are really pleased to see you and you’re helping out the local nurses it makes it worthwhile.’

The service launched just over two years ago (DDN, November 2011, page 19) with the aim of reaching those at risk of hepatitis C but unable, or reluctant, to access testing. The brief is to cover the whole of the UK, visiting drug services and hostels, as well as community centres for people from high-prevalence countries. ‘Some places have excellent services for hep C, so it’s pointless us going there,’ says Conneely. ‘Whereas other places really need a boost.’

Clients are offered a mouth swab test to determine the presence of antibodies that show if they’ve ever had the virus – but not if they currently do – with the results available in 20 minutes. If this proves positive, blood tests will then need to be carried out to determine if the person has the virus now. Everything is confidential, and so far more than 1,400 people have been tested in the van, of whom around 100 have identified hep C antibodies.

‘I was recruited specifically for the role,’ says Conneely. ‘The funding to initiate the van was through the Department of Health, so the trust bought it, equipped it and recruited me because they wanted someone with a clean licence who’d had hepatitis C. I’d worked in drug services for years and I just jumped at it.’

Properly publicising the visits in advance is vital, he stresses. ‘You can’t just turn up somewhere. There’s only me to organise it so I have to do the Hep vanback office stuff, the database and the event planning.’ Before a visit, the trust will email posters to the venue, talk to substance misuse staff and make sure there are clear pathways in place for people who test positive.

‘We get nurses coming in and local GPs with an interest in hep C come along as well,’ he says. ‘We try to get out a couple of days a week and we’ve been pretty successful at doing that, depending on where we are, but there’s one van for the whole of the UK so we tend to go where people have requested us to go. Plus everything’s so localised now that people don’t know what’s happening 30 miles away – we’ll find great practice at one place and then you go down the road and they’re completely ignorant around hep C. The gaps in provision are crazy, but we’re trying to target those.’

The first step is to take clients through the basics, he says, explaining the risk factors and finding out if they’ve been tested before. ‘If they have and they’re positive in any way it’s pointless me testing them – as the test I do is just an antibody test to show they’ve been in contact, they’ll need a blood test. I’ll go through all the risks with them and, if they’ve injected, it’s “get yourself tested”. Everyone’s at risk who’s injecting, but you also get the worried well coming in – I won’t put them off because I also believe that some people won’t say why they need a test.’

There are two people in the van wherever possible, he explains. ‘Sometimes it’s just me, depending on whether there’s help at the project, but if you get a queue of people you’ll need one person doing the testing and one on crowd control. We’ve never had any hostility – maybe local drug dealers occasionally, but once people realise we’re not the police it’s usually fine.’

Inevitably, some clients can react badly to a positive result, he says, which means a proper discussion before the test is vital so people can understand the implications as well as establish in advance if key workers and GPs can be informed. ‘Their GP might want to know what tests we did, so I write letters to the GPs and I also like to contact people after, but I won’t do that unless they specifically give me their consent.’

Consent can be a tricky issue with the client group, however. ‘You need to be careful,’ he says. ‘Consent is a judgement call with people who are Testdrinking and taking drugs, so it’s about whether I can have an ordinary conversation with them, regardless of how much they might smell of alcohol – you just have to judge it. Strictly speaking you could say, “I can’t talk to you, you’ve been drinking”, but we live in the real world and if people are drinking every day then that is their real world. It doesn’t mean they’re not able to communicate and give consent, but it’s crucial they sign the consent form – we won’t do anything without that, because we’re doing things with people, and any time anyone wants to pull out, that’s fine.’

Since the service launched, however, awareness raising and sharing information has come to be as important as the testing itself, he explains. ‘I wouldn’t say hep C’s complex, but people can still be unclear, plus a lot of what we’re doing is just helping to destigmatise it. People see the van with “Hepatitis C Trust” on the side in huge letters, and it’s, “some people have got hep C, get over it”. It’s helping to debunk some myths as well. It’s a blood-borne virus that’s difficult to catch unless you’re doing things that involve your skin being pierced. I remember saying I had hep C and it was, “Well, you’d better have your own cup now” and all the rest of it, but rehabs used to be like that. But the fact that I’ve had hep C and was using drugs until about 20 years ago is really helpful because it means I can communicate with people.’

The Department of Health funding is due to run out in April, however. What happens then? ‘Black hole scenario,’ he says. ‘But it is a front-line hep testservice so hopefully we’ll be able to find some funding sources. What we’d really like, rather than us doing this, is to get the local authorities to do it, because it makes economic sense and hep C is a public health issue. At the moment everything’s in a state of flux but it would be crazy to not fund an essential service, so we’ll just have to find a different way to do it.’

A lot of services do offer testing themselves though. ‘They might offer it, but do they actually do it?’ he says. ‘There’s world of difference. “Do you want a test? No, alright then” – then they’ve offered someone a test. BBV provision has been going downhill because it’s expensive and it’s a marginalised group. You’re even seeing contracts pulled from the mobile needle exchange services now – really successful services working with the street homeless. So if you’re not getting funding for services like that you do worry about hep C testing because there’s no immediate impact, whereas take away the needle exchange vans and straightaway you’ve got needles in the parks and so on.’

One thing that could ‘massively improve’ matters would be a greater focus on peer support, he stresses. ‘There seems to be a large hidden cohort of people who’ve been tested but then nothing happens. I hope that’s what we’re going to target next and we’re involved in a research project to try to get some evidence that people who have peer support get better outcomes. It does seem to be catching on that if you train the peers up they can support people to go and get the appointments for blood tests and follow-ups, and maybe get a support group in place.’

He’s adamant that this shouldn’t be staff-led, however. ‘That’s why we’re having this big push to try to get peers trained up so they do know what they’re talking about. People who have experience of drug use and having the virus are really helpful, because they’re listened to. A staff member in a rehab or drug service doing a talk – together with every other thing they’ve got to deal with and get across – isn’t going to get the information out so that people take it in. Peer intervention is key.’

Another crucial aspect is that if people ‘face up to their BBV status then they’ll maybe face up to their recovery status,’ he says. ‘One of the things hep c trust vanthat we’ve really noticed is most people who use drugs think they have hep C. But a lot of people haven’t got it, so we’ll say “why are you doing stuff to put yourself at risk?” No one wants to walk around paranoid thinking you’ve got a chronic illness when you haven’t, and you get all sorts of scare stories as well. So it’s about getting the truth out.’

To arrange a visit email Jim.Conneely@hepctrust.org.uk

Expert opinion

Analytical chemist Dr John Ramsey of TIC TAC is the media’s go-to man for an authoritative voice on new psychoactive substances. He talks to DDN’s David Gilliver.

John Ramsey‘It’s a really difficult phenomenon to name,’ says Dr John Ramsey of the new drugs he’s constantly adding to his organisation’s database. ‘None of the terms really work, and nobody understands them in any case. “Legal highs” is inappropriate because a lot of them don’t remain legal and a lot are depressant rather than highs, and “new psychoactive substances” nobody understands. We used to call them designer drugs, which I suppose is pretty much accurate but, again, nobody really understood it. It’s a bit like “Hoover” and “Biro” – we revert to “legal highs” because that’s what everyone understands.’

TICTAC Communications is a commercial company that’s part of St. George’s, University of London. It collects drugs into a huge database used by both the health and criminal justice sectors, and has existed in various guises since the early 1980s. ‘It was originally set up because the laboratory I was running at the time investigated deaths on behalf of coroners who needed to identify tablets and capsules, so it seemed a good idea to have a filing cabinet with samples and just look for them,’ says Dr Ramsey. ‘TIC TAC is actually older than the personal computer and the CD-Rom. All the changes in technology have allowed us to deliver the same data in different ways, but it’s still the same filing cabinets full of drugs.’

The plethora of new substances, however, means that he’s become a regular on drug-related news items, ‘purely because we’ve got them all here,’ he says. ‘We don’t do much else apart from collect drugs, legal and illegal, so we’re a source for news stories – a one-stop shop for drugs, I suppose.’

The speed at which new drugs are emerging makes it hard for people to keep up – treatment services and, particularly, legislators – and users often have absolutely no idea what’s in the substances they’re taking. ‘And even if we know what’s in them, we don’t know what they do,’ he adds. ‘It’s not too difficult to analyse drugs and find out chemically what they are, but knowing what the hazards and dangers are – and indeed whether they work as drugs – is a fairly major undertaking.’


As compounds are tweaked to stay ahead of the law, people are exposed to an ever-changing list of new chemicals, he points out. While there’s always the chance of another compound like MPTP – accidentally made by someone trying to make the analgesic MPPP and which led to irreversible Parkinson’s-like symptoms in everyone who took it – determining the scale of the risk is a challenge.

‘Everybody concentrates on deaths, and we all pick the alarming effects because they’re easy to talk about and dramatic, but there’s a lot of scope for harm below that,’ he stresses. ‘They could cause birth defects, all sorts of issues. There’s a whole group of stimulants that cause damage to heart valves, for example. There was an appetite suppressant called fenfluramine that was marketed for years until people established that it could cause valve damage, and some people who took it had quite serious heart problems.’

While the pharmaceutical industry carries out post-market surveillance, if any of the new psychoactive substances were causing similar problems ‘we’d never associate those health ill effects with them’, he says, and although with most compounds it would probably take a significant amount of time before issues became apparent, the potential is still there. ‘A classic example is ketamine,’ he states. ‘When used for its intended purposes it’s quite harmless, but when used inappropriately it can cause the bladder damage that everybody’s now focusing on.’

The ACMD recently recommended that ketamine be upgraded from class C to B, and the government has also announced a wide-ranging review of the laws relating to new psychoactive substances to report in the spring (see news stories, page 4 and 5). But what can realistically be done from a legal point of view – is New Zealand’s attempt to regulate them the right way to go? ‘I think everybody’s watching that with interest,’ he says. ‘I’m rather pleased they’re doing it but the thing that worries me is that clearly the compounds aren’t going to be evaluated to the same standard that the pharmaceutical industry would, purely because of the amount of money it costs and the amount of time it takes. Why as a society should we accept a lower standard of safety for a recreational drug than we do for a pharmaceutical?’

In the pharmaceutical industry it’s usually around five years before new drugs are tested on humans, he explains. ‘The processes are getting better, as we understand more about genetics and how these things might act, but there’s an awful lot of animal experimentation done before a compound ever gets near a human. So that’s the other issue with the New Zealand situation – we’ve then got the ethics of killing hundreds of animals to test the safety of these compounds. Is that right? I don’t know how much truth there is in this, but I’ve heard that some people who have applied for these new licences are getting death threats from animal rights protesters.’

The best approach, he believes, is firstly to clearly explain the risks to people – ‘the classic risk assessment of “is a small amount of pleasure on a Saturday night worth the risk of taking an unknown chemical?” and secondly, perhaps, to ‘just let the market regulate’.

‘If compounds are unpleasant and don’t work very well, people will stop buying them and they’ll disappear. Presumably we’ll finish up with the compounds that people like and we’ll then have a reasonable chance of observing what happens and deciding what the risks are. If we ban everything as soon as it appears all we do is spawn the production of new ones and expose people to more and more compounds.’

In terms of that sort of staying power, mephedrone has proved remarkably resilient, surviving its 2010 ban and with presentations to treatment services for problems with the drug doubling in the last year (DDN, December 2013, page 15). ‘I don’t know if that’s a good thing or a bad thing,’ he says. ‘There have been suggestions that falls in the number of cocaine deaths could be attributed to people using mephedrone instead – perhaps it’s a safer stimulant. But because mortality monitoring is so unregulated, and because the hospital A&E departments don’t really collect information in a way that we can collate it – and indeed don’t analyse samples from people who present with problems – we don’t really know what the health issues are.’ 


As well as drugs from police and border forces, TIC TAC analyses the contents of amnesty bins at nightclubs and festivals. ‘With Glastonbury it’s more of an amnesty skip but, having said that, we don’t actually see many legal highs there. It’s MDMA, cannabis, cocaine – the usual suspects,’ he says.

The organisation also regularly carries out test purchases from online shops – buying drugs with a credit card the same as any other customer – and although more and more new drugs are identified via the EU early warning service each year, whether those numbers ‘really mean anything’ or how many of the drugs could go on to pose a significant problem is difficult to determine. While it’s easy to test purchase and analyse any compounds that are offered for sale, what’s harder to know is how many people are actually using them, he stresses.

To find out more, TIC TAC has been carrying out waste water analysis as part of SEWPROF, an EU-funded project studying sewage epidemiology. ‘Once drugs become sufficiently established they can be detected in the sewage treatment works – we can detect mephedrone and most of the other drugs,’ he says, with MDMA levels unsurprisingly peaking sharply at weekends.

However, a relatively new drug won’t be used by enough people for that to be an appropriate method, so TIC TAC also installs public urinals and carries out anonymous, non-attributable analysis as ‘an early indicator of what’s being used and potentially where and when. If we stick a public urinal in Liverpool Street station on a Friday night we know that anyone who contributed to that did it over the past day or two, so that pinpoints their drug use to a few days and we hope to be able learn a bit about consumption this way. Just because a compound’s offered for sale doesn’t mean that anybody uses it.’ Although the urine testing is still in its early stages – and clearly won’t include female samples – there are already conclusions that can be drawn, he explains.

‘The new drugs are present in all the urine samples we’ve tested – we’ve never tested a public urinal that doesn’t have one of the new compounds in. One of the things a lot of people are concerned about is the cannabinoid receptor agonists, and kids getting themselves into trouble using those. Well, we don’t detect those in the public urinals. I don’t know whether that’s because our analytical methodology’s not up to the mark or because they’re not there, so there’s still research that needs to be done in evaluating our ability to detect these things. Of course it might well be that if they’re used it’s not in an environment that would result in them being in city centre urinals – if they’re used by younger people, maybe at home. There’s quite a lot of subtlety that needs considering when we draw conclusions.’

As to the question of where all the new compounds are coming from, most are still manufactured in China, he believes. ‘It’s difficult to know for certain, but certainly the work we’ve done with the UK Border Agency looking at importations into Heathrow from Shanghai shows a significant number of these new compounds, and if you type the name of a new compound into Google you’ll get an awful lot of Chinese chemical companies offering to sell them to you, so I’m pretty sure. It’s not exclusive to China – it’s a lucrative market, so anyone with the capability of doing it is likely to try.

‘Different drugs and precursors come from different places and people get stuff from wherever they can. It’s a free market, so people will just buy the stuff where they can get it cheapest.’

www.tictac.org.uk

Creating Recovery

creating_recovery_ebanner

Thursday 16 January 2014

The London Film Museum, London

Come and join colleagues from detoxification, abstinent-based treatment and rehabilitation centres, commissioning groups, public health, local authorities, police and crime commissioners and many more to identify assets needed for long term Recovery.

Government launches ‘legal high’ review

The government is to review the laws relating to new psychoactive substances, the Home Office has announced, in a bid to ‘clamp down on the trade in potentially fatally drugs’.

The review will have input from ‘law enforcement, science, health and academia’ and study international and other evidence, with findings to be presented in spring 2014. It will then ‘make a clear recommendation for an effective and sustainable UK-wide legislative response’ to the new drugs, with options including ‘the expansion of legislation to ensure police and law enforcement agencies have better tailored powers’. 

‘The coalition government is determined to clamp down on the reckless trade in so-called “legal highs”, which has tragically already claimed the lives of far too many young people in our country,’ said crime prevention minister Norman Baker. ‘Despite being marketed as legal alternatives to banned drugs, users cannot be sure of what they contain and the impact they will have on their health. Nor can they even be sure that they are legal. Our review will consider how current legislation can be better tailored to enable the police and law enforcement officers to combat this dangerous trade and ensure those involved in breaking the law are brought to justice.’

DrugScope said it ‘cautiously’ welcomed the review but added that legislation alone was not sufficient to address the problem. ‘This is an attempt by the Home Office to bolster current enforcement efforts and to see what other legislative options could be brought to bear on this new and complex drug situation,’ said chief executive Martin Barnes. ‘It is vital that education and information efforts are significantly enhanced in order to make the public – especially young people – more aware of the risks posed by experimenting with substances of unknown content and origin. These substances are not labelled ‘research chemicals’ by sellers for nothing.’

The Home Office has also announced that two groups of psychoactive substances currently under a temporary banning order – NBOMe and Benzofuran compounds – will become class A and B drugs respectively next year.  

See January’s DDN for a profile of new psychoactive drugs expert Dr John Ramsey

Families First 2013

FF10

Thank you to all the speakers, delegates and exhibitors who attended the 2013 Families First conference! 

Below you can view some of the presentations that were given on the day. Full coverage of the event can be found here.

Morning session

Kate McKenzie, mother and activist, gave a family perspective on the call for fair treatment:

 

Mark Gilman, the recovery lead for Public Health England, looked at how families can help their loved ones achieve recovery while looking after their own welfare:

 

Nick Barton, chief executive of Action on Addiction, looked at ‘tough love'” how do you keep a loved one’s recovery on track while looking after the needs of the family in their own right?:

 

Workshops

Alcohol and families, Lauren Booker – workplace manager, Alcohol concern:

 

Club drugs and legal highs, Becky Harris and Mark Dunn from The club Drugs Clinic:

 

Carers’ rights by The Princes Trust

 

Final session

Kate Peake of Adfam shared how new publicity techniques such as flash mobs can be used to talk about the challenges and benefits of speaking out for families:

Upgrade ketamine to class B, urges ACMD

Ketamine should be upgraded from a class C to class B drug, the Advisory Council on the Misuse of Drugs (ACMD) has recommended.

The recommendation follows increasing evidence of bladder damage caused by frequent use of the drug, says ACMD, as well as the growing numbers of people seeking treatment for ketamine-related problems – up from just over 100 to more than 800 in the five years to 2010/11.

The drug was controlled as class C in 2006, following a previous review by ACMD, with home secretary Theresa May telling the council in 2012 that a review of the latest evidence was ‘now warranted’ (DDN, April 2012, page 4).

While the drug is used safely in ‘a number of areas of human and vetinary medicine’, says Ketamine: a review of use and harm, frequent use in high doses can cause severe damage to the bladder, urinary tract and kidneys, with some heavy users having to undergo bladder removal.

Among the new report’s recommendations are that more is done to make people aware of the long-term physical risks of frequent use, as there is ‘currently no evidence-based ketamine education or prevention work being delivered in schools in the UK’, as well as awareness raising around how ‘the analgesic, anaesthetic and dissociative effects of ketamine can potentially make users vulnerable to robbery, assault and/or rape’.

The drug should also be considered as dependence-forming for some users, it says, and wants to see treatment services ‘able to respond to this need with NICE-recommended psychosocial interventions’. Healthcare practitioners – ‘particularly, but not just, GPs’ – should also be asking those presenting with unexplained urinary tract symptoms about ketamine use, it says.

‘The harm ketamine posed to users prompted the ACMD to recommend its control in 2004 – since then, we have seen evidence of a worrying trend of serious bladder damage occurring among frequent users,’ said ACMD chair Professor Sir Les Iversen. ‘In some cases this has led to young people having their bladder removed. It is a potentially dangerous drug at high doses and with frequent use with serious psychological and physical implications for those who misuse it. That is why we have recommended it is re-classified to class B and that there is an improved public health message around the risks associated with ketamine.’

DrugScope welcomed the review but said that reclassification would not be enough to address the public health problems associated with the drug. ‘Drug users, nightclub and festival staff and healthcare practitioners all need to be better informed about ketamine, its effects and potential for dependency,’ said director of communications and information, Harry Shapiro. ‘This is especially important in general health settings when people present with unexplained bladder problems, to prevent long-term and potentially life-changing health issues.’

Available at www.gov.uk/government/organisations/advisory-council-on-the-misuse-of-drugs

Familes First 2012

 

A big thank you to everyone who attended the conference!  See below to read tweets, see pictures and view presentations from the day. The conference was also covered in a special edition of DDN magazine — read it here.

The conference programme and speaker biographies can be found below:

DDN Adfam Conference Programme

Speaker Biographies

Workshop information

e: conferences@cjwellings.com

New injecting patterns fuel HIV risks

More people are injecting new psychoactive drugs, amphetamine-type substances and anabolic steroids, according to a report from Public Health England (PHE).

In England and Wales, HIV infection levels among people who inject image and performance-enhancing drugs (IPED), such as steroids or melanotan, is similar to that among people who inject heroin, warns Shooting Up: Infections among people who inject drugs in the UK 2012.

While needle and syringe sharing overall is lower than a decade ago, one in seven injecting drug users continue to share injecting equipment, says the report. The number of people injecting amphetamines or amphetamine-like substances such as mephedrone, however, almost tripled in the decade to 2012, with this using population less likely to have been tested for HIV or hepatitis C and more likely to report sharing.

While heroin remains the most commonly injected drug – either on its own or in combination with crack – changes in patterns of use ‘that increase infection risk need to be detected and responded to promptly’ in order to minimise harm, the document states. In many areas, IPED users are the largest group accessing needle exchange services, with one in ten having been exposed to one or more of HIV, hepatitis C or hepatitis B.

‘Viruses don’t discriminate,’ said PHE’s lead on injecting drug use, Dr Fortune Ncube. ‘We must maintain and strengthen public health interventions focused on reducing injection-related risk behaviours to prevent HIV and hepatitis infections among all drug users. This includes ensuring easy access for those who inject image and performance enhancing drugs to voluntary confidential testing services for HIV and hepatitis, as well as to appropriate sterile injecting equipment through needle and syringe programmes.’

Meanwhile, the overall number of people in drug treatment has continued to fall, according to PHE’s most recent statistics. The total number in treatment in 2012-13 was 193,575, down from 197,110 the previous year and a peak of almost 211,000 in 2008-09. People over 40 now constitute the largest group entering treatment, with 13,233 over 40s entering treatment for heroin or crack, up from 12,535 the previous year.

‘Drug misuse is by its nature a highly challenging issue to address and the indications are that the going is getting even tougher for services in meeting the needs of an evolving and increasingly complex treatment population,’ said PHE’s director of drugs and alcohol, Rosanna O’Connor.

Shooting up: infections among people who inject drugs in the UK 2012. An update: November 2013, and Drug treatment in England 2012-13 at www.gov.uk/government/organisations/public-health-england

Afghanistan sees record opium crop

Afghanistan’s opium poppy cultivation rose by 36 per cent this year, a record high, according to the UN, while opium produc­tion was up almost a half on the previous year, at 5,500 tons.

The area under cultivation in 2013 was almost 210,000 hectares, says the United Nations Office on Drugs and Crime’s (UNODC) 2013 Afghanistan opium survey, higher even than 2007’s peak of 193,000 hectares. Prices are also much higher than during the previous high-yield years of 2006-08, it says, with the ‘farm-gate value’ of opium production increasing by almost a third since last year.

One possible reason for the increased cultivation may be farmers trying to ‘shore up their assets as insurance against an uncertain future’ prior to next year’s withdrawal of international forces, says the document. Almost 90 per cent of cultivation takes place in nine southern and western provinces, including ‘the most insurgency-ridden provinces in the country’, with a significant slowdown in Afghanistan’s legal economy also predicted for next year.

The figures were ‘a warning, and an urgent call to action’, said UNODC executive director Yury Fedotov. ‘If the drug problem is not taken more seriously by aid, development and security actors, the virus of opium will further reduce the resistance of its host, already suffering from dangerously low immune levels due to fragmentation, conflict, patronage, corruption and impunity.’ 

Available at www.unodc.org

Good vibrations

Jam StraightKevin Westbury tells DDN about Jam Straight, a place where people in recovery can relax, socialise and enjoy some good music.

The vineyard community centre in Richmond upon Thames was opened in 2012 with a vision to continue the work with the homeless and people in crisis that had taken place previously on the premises. A three-tier strategy was formed: a morning drop-in café to work with rough sleepers and people in need, a social café to provide an afternoon place to socialise for local people and 6AQLive, a provision of a local youth service. It is the youth service that has developed its own vision – to enable and empower young people to engage with issues of homelessness.

In January 2013 I was approached by ‘Tom’. He was a man in recovery and a musician, and his idea was to have a safe meeting place
for people who were in recovery from addiction and had an interest in music. We talked for a while about how this would look and how we would connect with groups in the area who might have an interest.

After coming up with the name Jam Straight, we held our first session in the basement on a Saturday night and 14 people came along. As a team we decided that this immediately felt like a family that we would like to support. The attendees were very keen to hold more sessions and invite more friends – so we decided on Thursday evenings.

6AQLive provides young people with training in all aspects of event management and café management and operation, as well as accreditation through the AQA unit award scheme. As Jam Straight began, we realised that this was a great opportunity for young people to practise the skills they had learned and also have more awareness of the delicate issues around
addiction.

Having now run for several months, the Jam Straight sessions have more structure. We book in a local acoustic act to anchor the night, and attendees can bring their own instruments and perform to the group or just come to enjoy the atmosphere.

It has been a wonderful space to share with some amazing people, who are gifted and so friendly. It provides a safe place to socialise with freedom from temptation and a warm welcome. We want to promote this session, and in 2014 we will be holding one every fortnight so that it becomes a more regular venue for people in recovery.

The centre is fully equipped with a sound desk, lighting and PA, and includes a full café with ethically sourced coffee and homemade snacks. At present we are not charging for entry as we see the opportunity for people in recovery as more important – the café makes money and the young people get training opportunities.

For the community centre, Jam Straight is becoming a family of like-minded people with a passion for music, and for the patrons it’s Jam Straight bandmore than likely the very same. For me, when we run the sessions and it comes to closing time I really don’t want to go and wish we could just stay there for as long as possible. For the young people, I’m not sure that they see anything different about the people that come – only that the atmosphere is warm, inviting, and there is comfort in the safety of the venue.

Scott Cooper, a regular at the café, says ‘I go to Jam Straight because I love music of all types – even more so if it’s live! The atmosphere is nice and relaxed – it sort of reminds me of an old jazz club with the lighting and sound and leather sofas. Knowing that the money I am spending at the café is going straight back to help the community and people in crisis gives me a sense of wellbeing.

‘Jam Straight is one of the only non-alcoholic music venues in south west London. The JBL sound system and onboard soundman make sure it sounds sweet, while the friendly staff and cosy sofas make it a perfect venue for a night of original sounds and good coffee (and bring your guitar!).’

Jam Straight takes place on Thursday evenings, and will run fortnightly from 9 January 2014. For more information contact kev@vineyardcommunity.org

Letters

LettersThe DDN letters page, where you can have your say.

Please send letters and comments to claire@cjwellings.com to be included in the magazine.

 

 

 

Losing the plot

• ‘Personally I don’t think you should be on methadone – it’s legal smack!’

• ‘Safer injecting information is just enabling.’

Quotations from right-wing press or substance misuse workers? Recovery is a word that is used a lot, a word that can inspire hope and positive change, but increasingly it appears to be a word that is losing its meaning. One certain aspect of recovery is that one person’s version may differ from another’s.

I’m witnessing an increasing amount of evangelical approaches in frontline working, which is capable of being mean spirited and lacking in compassion or under­standing. Telling someone what they ‘need to’, ‘have to’ or have ‘got to’ do is not person-centred. Sadder still is that many adopting this style of working are ex-users themselves.

I have been labelled ‘anti-recovery’ in the past; I’m not, but I am pro-choice. Some might argue that addicts do not have the capability to make choices of their own, not good ones anyway. I’m not sure – and I’m also not sure if there is anything entirely ‘wrong’ with making the ‘wrong choice’. Surely we have the capacity to learn from our errors and are empowered by doing so.

Having previously felt like some sort of pariah when airing my concerns, it often makes me wonder how it feels for our most marginalised service users who just ‘don’t get it’ when it comes to embracing recovery. I doubt being told what to do adds much value to their often-damaged existence.

The recovery agenda has been penned by a government that does not care about vulnerable and marginalised people and it is naive to think otherwise. If recovery is a journey, then we must not lose sight of where someone is on their journey and what it means to them, if anything at all.

A Hindu swami once told me that there are hundreds of ways to reach the summit of a mountain; each path will let us admire the view. We may stumble along the way, we may stop on a ledge for some time and build a fire for warmth and comfort. These ledges may indeed be a summit enough for some. We were not discussing recovery but I think his words can still apply.

Jesse Fayle, DIP practitioner

 

Clear evidence

Malcolm Clayton responded to my Soapbox article in October’s DDN on whether the drug laws are having an adverse impact on recovery by wondering where ‘the faith in the criminal justice system to reduce the availability and accessibility comes from.’ (DDN, November, page 10).

In a recent review of recovery in the Annual Review of Clinical Psychology (‘Quitting drugs: quantitative and qualitative features’, 2013), G Heyman found that while drug dependency is often characterised as a chronic relapsing condition, in fact recovery was commonplace. In one of the reviewed studies, for example, Lopez-Quintero et al (‘Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence’, Addiction, 2011) found that of those addicted to cocaine, 27 per cent had stopped using the drug after two years, 51 per cent had stopped after four years, and 76 per cent had stopped after nine years.

According to Heyman, ‘The strong­est correlate of remission was legal status. For instance, the half-life of alcohol dependence was about four times longer than the half-life of co­caine dependence (16 and four years, respectively). The simplest explanation of this difference is that alcohol is legal and therefore more available.’ 

Within the addictions field we often prefer our personal views and experiences over the evidence. In this case however, the evidence does appear to show that there is a beneficial impact upon recovery from the fact that some drugs are illegal.

Neil McKeganey Ph.D, director, Centre for Drug Misuse Research

 

Not so smart

I run Alcohol Support Project East Yorkshire (ASPrEY) and we have two groups, one in Bridlington and one in Beverley. We use the SMART Recovery process ­– I have completed their facilitator course and our meetings are published on their website. We engage with the NHS who advise their patients when they finish the Hull and East Yorkshire Alcohol withdrawal programme to get in touch with us for ongoing support.

The local authority (East Riding of Yorkshire Council), which is now respon­sible under Public Health England for drug and alcohol treatment, take com­pletely the opposite view. They claim they are not ‘assured’ we provide suit­able advice, although they have no evidence whatsoever to back this up. In fact the people who attend our groups give excellent feedback to the NHS on how beneficial they have found our support. 

I have challenged the local authority on why they have (seemingly without a shred of evidence) kept us outside the treatment loop in East Yorkshire, and received no response. We have even been funded by the lottery! They have also excluded us from their quarterly treatment forum, again for no apparent reason. I rather suspect this is all politically motivated. There are no other user support groups in most of East Yorkshire. In fact I referred someone to the East Riding Alcohol Aftercare service recently for some 1:1 support. They can’t take anyone else on for a ‘few weeks’. 

I would have thought any voluntary user support would be most welcome. Apparently not. I wonder if any other readers have experienced similar obstacles?

Stephen Keane, chair, Alcohol Support Project East Yorkshire

  

First-rate lesson 

When I started working at the drug and alcohol inpatient unit I was told that one of my responsibilities would be to deliver the doctor’s information group. My immediate thought was this sounds really interesting but I also felt a bit apprehensive as I didn’t have any experience of this kind of teaching. Isn’t it interesting how during medical training we only really get to see people on a one-to-one basis or with their relatives present?

Seeing a group of service users together to give direct education would have been something of a rarity despite the emphasis nowadays on public health and preventative medicine. I started to feel more anxious over the prospect of delivering the group but didn’t have much time to ruminate as the first Friday soon approached. I had decided to talk about the link between substance misuse and mental health. I was struck by how honest the service users were about their personal experiences and my feelings of nervousness quickly diminished. There were a couple of occasions where I had to intervene as people were talking over each other, but apart from that it went smoothly.

It was interesting for me to see the group dynamics and I made some mental notes for the next week. Something else that became apparent to me during the group was that despite being able to identify many negative consequences of substance misuse this had not prevented them from becoming dependent. I would strongly recommend the experience of conducting groups to any trainee doctor and I feel privileged to have been given this opportunity.

Dr Tanya Walton, CT3 psychiatry doctor 

 

Wrong direction

I read Ingrid van Beek’s article with interest (‘A fine balance’, November, page 18). I think all these ‘rooms’ will do is to allow clients to view this as ‘extra gear’ or a ‘side-order’ of drugs in addition to what they will continue to use in any case, thus increasing the extent of their habits. It may well work with other types of intravenous substance misusers, but not opiate dependents, in my opinion.

There will also be ‘diversion’ of the clinical drugs issued onto others it was not intended for, a bit like the way communities are awash with street buprenorphine and methadone pres­ent­ly. I recently home-visited a client and he had accumulated six litres of methadone, stored in a kitchen cup­board! I once worked for a community drug service where 92 per cent of those clients already supposedly engaged with structured treatment journeys were still attending for needles, and with little motivation to change.

I can see it may help with the current harm reduction/maintenance philosophy, but for those of us working with an abstinence based model of treatment, this policy is of very little help, as experienced by the detrimental consequences of these ‘rooms’ throughout the Netherlands.

Neil Angus, drugs project worker and former heroin addict

Seeing purple

Last month Alex Boyt took the recovery move­ment to task. Alistair Sinclair, Richard Maunders and Melody Treasure of the UKRF respond

In DDN’s November issue Alex Boyt shared some of his thoughts on the ‘R’ word and this prompted much discussion on social media among the recovery community. It would be interesting to know if something similar happened within services. While Alex, tongue located somewhere in his cheek, has a poke at the ‘purple t-shirt’ brigade (we’re  fully signed-up members) and the ‘warm fuzzy feelings’ found at recovery gatherings, it seems to us that he is principally ‘venting’ about services/commissioners and their interpretation of ‘recovery’.

Alex is a SU coordinator in central London. In his article he refers to commissioners, the NTA, Theresa May and the PHE strategic recovery lead. We believe (and we met with Alex to talk about his piece) that he is asking some important questions: has the mass importing of recovery ‘rhetoric’ into the drug field and the establishment of recovery plans/ champions/ pathfinders /colleges/ trees etc resulted in services that are more recovery-oriented? Do new recovery-branded services ‘speak’ to the most ‘dis­ad­vant­aged, traumatised and neglected’? Or are they serving a politicised neo-liberal agenda (one recovery agenda among many) that increasingly commodifies support and people and, as Alex suggests, uses a ‘recovery agenda’ to categorise SUs as ‘deserving’ or ‘undeserving’? These are uncom­fortable questions, and we thank Alex for having the courage to ask them.

However, we’re not sure that reducing the vast diversity of ‘recovery’ found in communities to purple-clad ‘happy-clappy’ individuals who enjoy a hug and a ‘hurrah’ is the best way to highlight important service issues. Sorry Alex. There is clearly a way to go before we can happily sit back and say we have recovery-oriented services, just as there is much work to be done by community members to increase access to inclusive recovery networks that support wellbeing. But – and it’s a big but – there is evidence, and lots of it (check out the 2007 Foresight study, Mental capital and wellbeing) that wellbeing is generated and sustained through opportunities to be active, learn, take notice, connect and give (the ‘five ways to wellbeing’).

Most of the opportunities to do this can be found in what Edgar Cahn calls the ‘core economy’: family, neighbourhood and community. People have been finding their version of recovery, abstinent or otherwise, in the core economy for decades, centuries, long before services came along. The emerging recovery movement (in drugs and mental health) has started to make the core economy more visible in recognition of its increasing importance. Five thousand people on a recovery walk, many of them marginalised in the past, and 50 recovery events in recovery month is evidence of something, as is the emergence of new recovery communities all over the UK.

We need to work together to support new communities, encourage more traffic between them and widen the doors. We are all in this together and we believe, if we are going to find new ways of responding to old problems, we need to have more faith in the capacity of people within communities to define and shape their own recovery. 

‘Take the first step in faith. You don’t have to see the whole staircase, just take the first step’ – Martin Luther King, Jr.

The authors are directors of the UK Recovery Federation (UKRF)

 

Matter of life and death

Why in the name of public health is naloxone distribution still a postcode lottery, asks Neil Hunt.

I live in Kent, one of 16 sites from the 2010 NTA naloxone pilots for families and carers of heroin/opioid users. Locally, ‘Take Home Naloxone’ (THN) for service users, their families or carers has since become integral to our treatment system due to the numerous, ongoing, successful, docu­mented overdose reversals. Yet this week, I received an email from a col­league 240 miles away in NW England asking if I knew how to help a man living 140 miles away in Peterborough, a city 120 miles from me.

He wanted THN for two close friends who were just leaving prison and – as he quite rightly understood – were at much heightened risk of overdose. He is highly educated and computer literate, yet had been unable to obtain this potentially life-saving medicine. To see if he was overlooking anything obvious, I did the natural thing and Googled ‘Peterborough’ AND ‘naloxone’; however, I couldn’t find any information about its availability, let alone how a heroin user, their lover, parent, son or daughter might obtain it.

The latest published UK drug-related death data show that, annually, Peterborough has 6.21 drug-related deaths per 100,000 population – largely opiate-related ie ones for which THN is relevant. This is pretty much the midpoint rate between those UK localities with the highest and lowest drug-related death rates. In plain English, in Peterborough and places like it, year-on-year a modest number of opiate users die from overdoses, some of which are almost certainly preventable.

It’s important to emphasise that the fact that this happened in Peterborough is almost entirely incidental. It’s just where one persistent guy lives. I barely know the city/its services and have no reason whatsoever to think they are any better or worse than those elsewhere. On the contrary, Peterborough’s services could be truly excellent in all respects other than its THN service. I honestly have no idea.

The crucial point is that this well-informed, justifiably concerned friend could have lived in numerous, similar English cities where THN is unavailable. Or, conversely, assorted other areas where THN is actively promoted. His ability to take measures to reverse a friend’s potentially fatal opioid overdose is determined in an arbitrary way, according to where he lives. A situation that would be regarded as intolerable if it were applied to, say, provision of patient-held adrenaline for people with a history of anaphylaxis from bee-stings.

Clearly, we should be cautious about deducing too much from one isolated case, however many hundred miles of unnecessary communication it involved. Nevertheless, I’d argue that this example warrants serious consideration for several reasons:

a) A Peterborough citizen and taxpayer who cares for his friends and under­stands the risks and issues around heroin overdose sought help via two perceived ‘experts’ on different sides of the country across about 500 miles, only to be told, ‘Sadly, it’s up to your local commissioners. If they don’t fund THN then you can’t get it.’ This seems a very potent illustration of well-informed demand in an area where drug-related deaths need to be reduced.

b) Anecdotally, harm reduction, needle exchange, active drug user and recovery networks often hear that the ‘THN availability problem’ is widespread, yet no reliable mapping of English THN outlets/availability exists. An interactive naloxone finder database is being developed for Scotland in a way that could be extended across the UK (www.naloxone.org.uk), but England currently lacks both coordination and strategic vision in its approach to THN, rendering it both less effective than it might be and probably with higher unit costs too.

c) Public Health England (PHE) is currently navigating its way through complex political and organisational changes and clarifying its role at a time of economic austerity. THN is an affordable intervention that naturally fits within public health and could potentially benefit from comprehensive PHE advocacy and support. At present, many commissioners and providers of drug services and, vitally, many of the people who are most likely to witness an overdose – opiate users and their friends, families and lovers – seem barely aware of its existence.

Take Home Naloxone is a potentially important test of the role that Public Health England will fulfil in the new system in which we are now operating. PHE is not responsible for the THN policy shambles it has inherited. Nevertheless, in 12 months time, if people who need THN to protect the lives of those they care for are still jumping through such tortuous, long-distance hoops, only to discover that they are arbitrarily denied services that are readily available in an adjoining locality, I think many people may be left questioning whether ‘public health’ has been well served, and how PHE can in any way claim to be an agency that serves all of ‘England’.

Neil Hunt is honorary research fellow, The Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine and honorary senior research associate, School of Social Policy, Sociology and Social Research, University of Kent

 

 

Every step

We have a duty of care – from the recovery position to the recovery journey, says Dr Steve Brinksman.

If you have read this column before, you will know that I am always keen to promote recovery, defined by the individual in respect of their own journey and not from a political or ideological concept. That said I am reasonably long in the tooth and, having worked with people who use heroin for 20 years, I am well versed in the concepts of harm minimisation. The truism ‘dead people don’t recover’ springs to mind. Harm reduction is the solid foundation on which we can build future recovery. 

With this in mind, the treatment system I operate within in Birmingham has now started actively encouraging service users to undergo training in the administration of naloxone for the treatment of suspected opioid overdose, alongside placing the person in the recovery position and calling an ambulance. I have been told that ‘people in treatment shouldn’t need prescriptions for naloxone’, yet I have come across people in treatment who have used naloxone to reverse overdose in people outside of the treatment system, and I am sure we would all accept that, despite people’s best intentions, use on top of a script occurs. There have been enough uses of naloxone in Birmingham for me to be confident that there are people alive today who would not have been were it not for the availability of naloxone.

To back this up there is growing evidence from around the world that it is not only clinically effective, but that it can be safely administered by peers and reduce overdose deaths. Our service users have embraced this, but in a system with a large number of GPs operating in a community setting, it is proving more of a stumbling block to get these clinicians involved, a vital step if prescriptions are to be issued. Talking to colleagues around the UK shows that we are not alone in this.

There are a number of ways to try and address this. The National Treatment Agency [NTA] supported a number of pilot sites and in 2011 produced a report recommending it – The NTA overdose and naloxone training programme for families and carers, http://bit.ly/1cz0r99

The Medicines and Healthcare products Regulatory Agency (MHRA) has just announced a consultation on a proposal to allow wider access to naloxone for the purpose of saving life in an emergency. The consultation runs until 7 February 2014 and is available online at http://bit.ly/1aRGS9b

At SMMGP we recognise that lack of knowledge and training are significant factors that hold clinicians back from adopting new treatment approaches, and so we have committed to developing a free to access e-module that will cover the rationale behind naloxone prescribing as well as the practical aspects.

We also need those of you who work with clinicians, those who commission services and those who provide education to recommend the prescribing of naloxone. Drug-related deaths from overdose remain a significant problem and I believe a widespread roll-out of naloxone could significantly reduce this. We have as much a duty of care to people who use, as we do to those at any stage of their recovery.

Steve Brinksman is a GP in Birmingham and clinical lead of SMMGP. www.smmgp.org.uk. He is also the RCGP regional lead in substance misuse for the West Midlands

 

News in brief

HIV action

A new three-year HIV prevention programme has been backed by the leaders of all 33 London boroughs, with more than £3m allocated to run the project until 2017. Eighteen of the 20 local authorities with the highest diagnosed HIV prevalence are in the capital, which saw its first increase in new cases for a decade – 8 per cent – in 2012. ‘It is alarming to see such a sharp increase in HIV diagnoses, but London boroughs have been quick to act,’ said London Councils executive member for health, Theresa O’Neill. Earlier this year the National Aids Trust warned that London’s councils were failing to respond appropriately to increasing levels of high-risk drug use in parts of the gay community.

What’s all this then?

The Home Affairs Committee has announced an enquiry into the effectiveness of police and crime commissioners (PCCs). Despite being a ‘key part’ of the new policing landscape, their work ‘has not been without controversy,’ said committee chair Keith Vaz, while the Independent Police Commission’s Policing for a better Britain report stated that the ‘experiment’ with elected PCCs had been ‘riddled with failings’. A separate report has been issued by the Revolving Doors Agency, focusing on PCC responses to groups such as young adults and people with complex needs. Meanwhile, seizures of class A drugs fell by 3 per cent in 2012/13, according to the Home Office, while class B seizures fell by 10 per cent.

Policing for a better Britain at independentpolicecommission.org.uk, First generation: one year on at www.revolving-doors.org.uk, Seizures of drugs in England and Wales, 2012/13 at www.gov.uk

Phoenix finalists

Welsh band CoverUp from Bridgend have been named winners of Phoenix Futures’ Re:Cover music project (DDN, September, page 5). Other finalists were Common Ground from Glasgow, Leeds rapper Nate, singer/songwriter Adam Norrie from Sheffield, Essex-based Rob the Liar, London solo artist MJ Lines, Leicester band Maya and Phoenix Voices, a choir featuring community members from Phoenix’s Wirral residential service.

Hear them all at www.phoenix-futures.org.uk/recover

Older options 

A pocket guide on preventing alcohol-related harm to older people has been published by the British Association of Social Workers (BASW). The guide contains a section of dos and don’ts as well as effective approaches for interventions.

Alcohol and older people available at www.skillsconsortium.org.uk 

Underlying causes

Drug services should increase their focus on underlying traumas and difficulties, according to a new report from the Scottish Drugs Forum (SDF). High quality psychological therapies need to be more widely available, says Trauma and recovery amongst people who have injected drugs within the past five years, with failure to respond effectively storing up future problems for individuals, families and society. Interviewees’ drug use was primarily a ‘dysfunctional coping response’, says the document. ‘We hope that the findings of this research will help challenge the all-too-common perception that a person’s drug problem is a lifestyle choice or “self inflicted”,’ said SDF director David Liddell. ‘We need to recognise and take action on the wider factors underpinning substance use dependency which have blighted generations of disadvantaged families across Scotland.’

 Available at www.sdf.org.uk 

Hep step

A commitment to introduce an opt-out test for hepatitis C and other blood-borne viruses by next April has been included in a partnership agreement on co-commissioning health services in prisons between the National Offender Management Service (NOMS), NHS England and Public Health England (PHE). It is thought that up to one in ten prisoners has hepatitis C, a virus that is ‘grossly underprioritised’ according to the Hepatitis C Trust (DDN, November, page 4). Trust policy advisor Becky Hug called the agreement a ‘brilliant step forward to improving public health, both inside and outside prison walls’.

PbR problems

Payment by results has suffered from ‘crude implementation’, according to a report from the National Council for Voluntary Organisations (NCVO), with some contracts failing to account for the complex nature of services or containing targets irrelevant ‘or even detrimental’ to the desired outcomes. ‘Implementing PbR effectively requires intelligent thought and carefully crafted incentives, but many PbR contracts fall well short of this,’ said NCVO chief executive Sir Stuart Etherington. ‘Crudely designed targets and contracts risk pushing expert voluntary sector providers out of public service provision.’ 

Payment by results contracts: a legal analysis of terms and process at www.ncvo.org.uk

Welsh deaths down 

The number of deaths related to drug misuse in Wales fell to just over 130 last year from more than 150 in 2010, according to Welsh Government statistics. More than 200 lives have also been saved since 2009 through the take-home naloxone campaign, the government says. Substance misuse in Wales 2012-13 and Working together to reduce harm: substance misuse strategy annual report 2013 at wales.gov.uk